{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                "http://www.ncbi.nlm.nih.gov/pubmed/20403221",
                "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                "http://www.ncbi.nlm.nih.gov/pubmed/20042385",
                "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                "http://www.ncbi.nlm.nih.gov/pubmed/18215414",
                "http://www.ncbi.nlm.nih.gov/pubmed/17933469",
                "http://www.ncbi.nlm.nih.gov/pubmed/27726944",
                "http://www.ncbi.nlm.nih.gov/pubmed/21574432",
                "http://www.ncbi.nlm.nih.gov/pubmed/24531712"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 120,
                    "offsetInEndSection": 212,
                    "text": "Soft tissue sarcomas appear to use the alternative lengthening of telomeres more frequently."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1231,
                    "offsetInEndSection": 1412,
                    "text": "Alternative lengthening of telomeres and/or loss of ATRX were uncommon in malignant peripheral nerve sheath tumors, gastrointestinal stromal tumors, and embryonal rhabdomyosarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Telomerase activation and alternative lengthening of telomeres are two major mechanisms of telomere length maintenance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1993,
                    "offsetInEndSection": 2128,
                    "text": "We conclude that alternative lengthening of telomeres is a frequent telomere-maintenance mechanism in cytogenetically complex sarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 197,
                    "text": "Alternative lengthening of telomeres is a telomere-maintenance mechanism common in sarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 371,
                    "offsetInEndSection": 567,
                    "text": "We previously reported that alternative lengthening of telomeres and loss of ATRX expression were common in leiomyosarcoma, angiosarcoma, pleomorphic liposarcoma, and dedifferentiated liposarcoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 454,
                    "text": "Loss of \u03b1-thalassemia/mental retardation syndrome X-linked (ATRX) or death domain-associated protein 6 (DAXX) expression has been implicated in the pathogenesis of alternative telomere lengthening in pancreatic endocrine neoplasm and glioma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20403221",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 364,
                    "text": "However, some cancer cells maintain telomere length through an alternative mechanism termed 'alternative lengthening of telomeres'."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1413,
                    "offsetInEndSection": 1541,
                    "text": "By contrast, none of the 71 gene fusion-associated sarcomas was ATRX deficient or alternative lengthening of telomeres positive."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                "http://www.ncbi.nlm.nih.gov/pubmed/24385972",
                "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                "http://www.ncbi.nlm.nih.gov/pubmed/25215270",
                "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                "http://www.ncbi.nlm.nih.gov/pubmed/23963681",
                "http://www.ncbi.nlm.nih.gov/pubmed/26993043",
                "http://www.ncbi.nlm.nih.gov/pubmed/22302876",
                "http://www.ncbi.nlm.nih.gov/pubmed/28039838"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1262,
                    "text": "Finally, we discuss the current understanding of the actions of FGF21 as a crucial regulator mediating beneficial metabolic effects of therapeutic agents such as metformin, glucagon/glucagon-like peptide 1 analogues, thiazolidinedione, sirtuin 1 activators, and lipoic acid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Fibroblast growth factor 21 (FGF21) is a peptide hormone that is synthesized by several organs and regulates energy homeostasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 140,
                    "offsetInEndSection": 323,
                    "text": "Fibroblast growth factor 21 (FGF21), a hormone induced by a variety of environmental or metabolic stimuli, plays a crucial role in the adaptive response to these stressful conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 324,
                    "offsetInEndSection": 529,
                    "text": "In addition to its role as a stress hormone, FGF21 appears to function as a mediator of the therapeutic effects of currently available drugs and those under development for treatment of metabolic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25215270",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Fibroblast growth factor 21 (FGF21) is an endocrine hormone that is primarily expressed in the liver and exerts beneficial effects on obesity and related metabolic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 310,
                    "text": "Excitement surrounding this relatively recently identified hormone is based on the documented metabolic beneficial effects of FGF21, which include weight loss and improved glycemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 198,
                    "text": "The placenta actively synthesizes and secretes many hormones, but it is unknown whether this includes FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 263,
                    "text": "FGF21 is mainly expressed in the liver, but is also found in other tissues including the intestine, which expresses \u03b2-klotho abundantly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 800,
                    "offsetInEndSection": 938,
                    "text": "Gene silence and inhibition of hypoxia-inducible factor-\u03b1 (HIF\u03b1) did not affect the reduction of FGF21 mRNA and protein levels by hypoxia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1022,
                    "offsetInEndSection": 1178,
                    "text": "The addition of n-acetylcysteine (NAC) suppressed CoCl(2)-induced reactive oxygen species (ROS) formation and completely negated CoCl(2)-induced FGF21 loss."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                "http://www.ncbi.nlm.nih.gov/pubmed/27956554",
                "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                "http://www.ncbi.nlm.nih.gov/pubmed/18793140",
                "http://www.ncbi.nlm.nih.gov/pubmed/25742093",
                "http://www.ncbi.nlm.nih.gov/pubmed/18247557",
                "http://www.ncbi.nlm.nih.gov/pubmed/29074978",
                "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                "http://www.ncbi.nlm.nih.gov/pubmed/23863900"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 124,
                    "offsetInEndSection": 305,
                    "text": "Similar to ubiquitination, neddylation is mediated by a cascade of three NEDD8 specific enzymes, an E1 activating enzyme, an E2 conjugating enzyme and one of the several E3 ligases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Neddylation is a post-translational protein modification that conjugates a ubiquitin-like protein NEDD8 to target proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 306,
                    "offsetInEndSection": 396,
                    "text": "Neddylation is countered by the action of deneddylases via a process termed deneddylation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 397,
                    "offsetInEndSection": 678,
                    "text": "By altering the substrate's conformation, stability, subcellular localization or binding affinity to DNA or proteins, neddylation regulates diverse cellular processes including the ubiquitin-proteasome system-mediated protein degradation, protein transcription, cell signaling etc."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1195,
                    "offsetInEndSection": 1373,
                    "text": "This work sheds new light on the roles of NEDD8 lysines on neddylation cascades and provides a dominant negative mutant for the study of neddylation and its biological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 679,
                    "offsetInEndSection": 799,
                    "text": "Dysregulation of neddylation has been linked to cancer, neurodegenerative disorders, and more recently, cardiac disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742093",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 261,
                    "text": "Protein neddylation, a newly characterized posttranslational modification that adds the ubiquitin-like molecule NEDD8 to substrates, modulates important biological processes, whereas dysfunction of neddylation may cause several serious diseases, such as cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1194,
                    "text": "Therefore, this mutation completely inhibits global protein neddylation, including neddylation of cullin family proteins, resulting in decreased activity of cullin-RING E3 ligases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 622,
                    "offsetInEndSection": 713,
                    "text": "Our experiments discover that Lys27 in NEDD8 is a critical residue for protein neddylation."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                "http://www.ncbi.nlm.nih.gov/pubmed/24310611",
                "http://www.ncbi.nlm.nih.gov/pubmed/18054789",
                "http://www.ncbi.nlm.nih.gov/pubmed/11331601",
                "http://www.ncbi.nlm.nih.gov/pubmed/23573231",
                "http://www.ncbi.nlm.nih.gov/pubmed/23881940",
                "http://www.ncbi.nlm.nih.gov/pubmed/23361013"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 467,
                    "text": "When DNA double-strand breaks are induced at specific sites in the chromosome, Tn7 transposition is stimulated and insertions are directed proximal to the induced break."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Broken replication forks result in DNA breaks that are normally repaired via homologous recombination or break induced replication (BIR)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Tn7 transposes proximal to DNA double-strand breaks and into regions where chromosomal DNA replication terminates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 599,
                    "text": "The targeting preference for the terminus of replication and DNA double-strand breaks is dependent on the Tn7-encoded protein TnsE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Double-strand breaks in DNA can be repaired by homologous recombination including break-induced replication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "We report that the bacterial transposon Tn7 can preferentially transpose into regions where chromosomal DNA replication terminates."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Break-induced replication requires DNA damage-induced phosphorylation of Pif1 and leads to telomere lengthening."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 297,
                    "text": "DNA double-strand breaks are associated with the termination of chromosomal replication; therefore, we directly tested the effect of DNA breaks on Tn7 transposition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 359,
                    "text": "Break-induced replication has also been suggested to cause different types of genome rearrangements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11331601",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 221,
                    "text": "However, cells can repair DSBs by recombination-dependent, break-induced replication (BIR)."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29081339",
                "http://www.ncbi.nlm.nih.gov/pubmed/19464351",
                "http://www.ncbi.nlm.nih.gov/pubmed/27709630",
                "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                "http://www.ncbi.nlm.nih.gov/pubmed/545928",
                "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                "http://www.ncbi.nlm.nih.gov/pubmed/24885373",
                "http://www.ncbi.nlm.nih.gov/pubmed/19224235",
                "http://www.ncbi.nlm.nih.gov/pubmed/24300950",
                "http://www.ncbi.nlm.nih.gov/pubmed/24822215"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29081339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 955,
                    "offsetInEndSection": 1149,
                    "text": "RESULTS\nPeripheral blood monocytes were found to differentiate into fibrocytes in vitro in a time-dependent manner, and exposure to crystalline silica might potentiate fibrocyte differentiation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29081339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Crystalline Silica Promotes Rat Fibrocyte Differentiation in Vitro, and Fibrocytes Participate in Silicosis in Vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464351",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "There are several subtypes of fibrocyte in the spiral ligament and spiral limbus of the cochlea that may contribute to fluid homeostasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 793,
                    "offsetInEndSection": 951,
                    "text": "The activated fibrocyte build the collagen of the granulation tissue and then remodel and ensure wound contraction by becoming fibroclasts and myofibroblasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885373",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1655,
                    "offsetInEndSection": 1780,
                    "text": "In particular, the PDGF-BB-PDGFR-\u03b2 biological axis might play a critical role in fibrocyte migration into the fibrotic lungs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29081339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1303,
                    "offsetInEndSection": 1421,
                    "text": "CONCLUSION\nSilica exposure potentiates fibrocyte differentiation, and fibrocytes may participate in silicosis in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27709630",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1412,
                    "offsetInEndSection": 1599,
                    "text": "CONCLUSION\nWe have demonstrated that two circulating populations of fibrocyte exist in COPD, with distinct clinical associations, but are not prevalent in proximal or small airway tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 261,
                    "text": "Fibrocytes secrete profibrotic mediators including periostin; a matricellular protein that regulates cellular interactions with extracellular matrix (ECM) components."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 482,
                    "offsetInEndSection": 673,
                    "text": "We describe here the various stages of the differentiation of the wound edge fibrocyte into an activated fibrocyte and its proliferation and migration from the edges to the site of the wound."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/29036538",
                "http://www.ncbi.nlm.nih.gov/pubmed/28890290",
                "http://www.ncbi.nlm.nih.gov/pubmed/26853553",
                "http://www.ncbi.nlm.nih.gov/pubmed/28790415",
                "http://www.ncbi.nlm.nih.gov/pubmed/27307343",
                "http://www.ncbi.nlm.nih.gov/pubmed/26872375",
                "http://www.ncbi.nlm.nih.gov/pubmed/26687445",
                "http://www.ncbi.nlm.nih.gov/pubmed/27284320",
                "http://www.ncbi.nlm.nih.gov/pubmed/27895893"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1337,
                    "offsetInEndSection": 1457,
                    "text": "Intriguingly, among the conserved lncRNAs, h19, rmrp and hotair were also induced in a mouse model of heart hypertrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1180,
                    "text": "RESULTS\nFourteen lncRNAs were significantly modulated in non end-stage heart failure patients, identifying a heart failure lncRNA signature."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1788,
                    "offsetInEndSection": 1983,
                    "text": "Gene ontology analysis of the mRNAs displaying a significant correlation in expression with heart failure lncRNAs identified numerous pathways and functions involved in heart failure progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1181,
                    "offsetInEndSection": 1336,
                    "text": "Nine of these lncRNAs (CDKN2B-AS1/ANRIL, EGOT, H19, HOTAIR, LOC285194/TUSC7, RMRP, RNY5, SOX2-OT and SRA1) were also confirmed in end-stage failing hearts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 874,
                    "offsetInEndSection": 1037,
                    "text": "Function of the deregulated lncRNA was explored analyzing the expression of the neighbor mRNAs and by gene ontology analysis of the correlating coding transcripts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "BACKGROUND\nLong noncoding RNAs (lncRNAs) are non-protein coding transcripts regulating a variety of physiological and pathological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1636,
                    "offsetInEndSection": 1787,
                    "text": "Interestingly, RMRP displayed a ubiquitous nuclear distribution, while H19 RNA was more abundant in blood vessels and was both cytoplasmic and nuclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 333,
                    "text": "The aim of this study is to identify and characterize lncRNAs deregulated in patients affected by ischemic heart failure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 802,
                    "offsetInEndSection": 873,
                    "text": "LncRNA distribution in the heart was assessed by in situ hybridization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1986,
                    "offsetInEndSection": 2089,
                    "text": "CONCLUSIONS\nThese data strongly suggest lncRNA implication in the molecular mechanisms underpinning HF."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26934530",
                "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                "http://www.ncbi.nlm.nih.gov/pubmed/28061552",
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/26912916",
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                "http://www.ncbi.nlm.nih.gov/pubmed/27481004",
                "http://www.ncbi.nlm.nih.gov/pubmed/27456981"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 287,
                    "offsetInEndSection": 490,
                    "text": "Dinutuximab, an IgG1 human/mouse chimeric switch variant of murine monoclonal antibody 14G2a, binds to GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26934530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 811,
                    "offsetInEndSection": 958,
                    "text": "The combination of cytokines IL-2 and GM-CSF with the anti-GD2 MoAb ch14.18 (Dinutuximab) has shown a significant improvement in outcome for HR-NB."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "United Therapeutics Corporation and the National Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Dinutuximab is a monoclonal antibody targeted at disialoganglioside (GD2), a tumor-associated antigen widely expressed in human neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 467,
                    "text": "SUMMARY\nDinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 939,
                    "offsetInEndSection": 1343,
                    "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 491,
                    "offsetInEndSection": 635,
                    "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28061552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 323,
                    "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1661,
                    "text": "CONCLUSION\nDinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/28911122",
                "http://www.ncbi.nlm.nih.gov/pubmed/24782889",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                "http://www.ncbi.nlm.nih.gov/pubmed/25249628",
                "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/27550178",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 544,
                    "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 545,
                    "offsetInEndSection": 775,
                    "text": "The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "ChIP-exonuclease (ChIP-exo) is a modified ChIP-seq approach for high resolution mapping of transcription factor DNA sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 324,
                    "text": "We describe an Illumina-based ChIP-exo method which provides a global improvement of the data quality of estrogen receptor (ER) ChIP and insights into the motif structure for key ER-associated factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 468,
                    "text": "ChIP-exo of the ER pioneer factor FoxA1 identifies protected DNA with a predictable 8\u00a0bp overhang from the Forkhead motif, which we term mesas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 848,
                    "text": "The ChIP-exo libraries are then subjected to high throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "This unit describes the ChIP-exo methodology, which combines chromatin immunoprecipitation (ChIP) with lambda exonuclease digestion followed by high-throughput sequencing."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                "http://www.ncbi.nlm.nih.gov/pubmed/7605803",
                "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                "http://www.ncbi.nlm.nih.gov/pubmed/24115352",
                "http://www.ncbi.nlm.nih.gov/pubmed/15313545",
                "http://www.ncbi.nlm.nih.gov/pubmed/2813377",
                "http://www.ncbi.nlm.nih.gov/pubmed/22529999",
                "http://www.ncbi.nlm.nih.gov/pubmed/1627156",
                "http://www.ncbi.nlm.nih.gov/pubmed/12090301"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 554,
                    "offsetInEndSection": 824,
                    "text": "RESULTS\nHere, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 848,
                    "text": "Furthermore, we discover that the most frequent deletion breakpoints occur within or near predicted structures, a result that is supported by data from transgenic mice with mitochondrial disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1734,
                    "offsetInEndSection": 1863,
                    "text": "Notably, the most frequent deletion breakpoints, including those of the \"common deletion\", are bounded by 2G QFP sequence motifs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Association of G-quadruplex forming sequences with human mtDNA deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 188,
                    "offsetInEndSection": 443,
                    "text": "Guanine-quadruplex (GQ) DNA structures are associated with nuclear DNA instability in cancer; recent evidence indicates they can also form in mitochondrial nucleic acids, suggesting that these non-B DNA structures could be associated with mtDNA deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1074,
                    "offsetInEndSection": 1321,
                    "text": "We analyzed the position of each motif set relative to either 5' or 3' unique mtDNA deletion breakpoints, and found that intrastrand QFP sequences, but not ddi QFP sequences, showed significant association with mtDNA deletion breakpoint locations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7605803",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 608,
                    "text": "A pair of extremely short mirror sequences flanking the mitochondrial DNA breakpoints were identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 244,
                    "text": "The large majority of mitochondrial DNA (mtDNA) deletions analyzed from mitochondrial myopathies and aging humans have been found to be flanked by direct repeats, a finding which has led to the slip-replication hypothesis of deletion formation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Direct repeat sequences are not required at the breakpoints of age-associated mitochondrial DNA deletions in rhesus monkeys."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7605803",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "We characterized a mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                "http://www.ncbi.nlm.nih.gov/pubmed/19010924",
                "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                "http://www.ncbi.nlm.nih.gov/pubmed/850304",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725737",
                "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                "http://www.ncbi.nlm.nih.gov/pubmed/9154796",
                "http://www.ncbi.nlm.nih.gov/pubmed/29081691"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Circular RNAs (circRNAs) are a type of non-coding RNA molecules that lack a 5'-terminal cap and 3'-terminal poly A tail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "Circular RNAs (circRNAs) are a naturally occurring type of universal and diverse endogenous noncoding RNAs which unlike linear RNAs, have covalently linked ends."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 286,
                    "text": "They are usually stable, abundant, conserved RNA molecules and often exhibit tissue/developmental-stage specific expression."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Circular RNAs as potential biomarkers for cancer diagnosis and therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19010924",
                    "endSection": "abstract",
                    "offsetInBeginSection": 846,
                    "offsetInEndSection": 1091,
                    "text": "These antisense RNA molecules originate in the early region of the SV40 circular chromosome and proceed in antisense orientation into the late gene region, leading to the formation of highly unstable double-strand RNA, which is rapidly degraded."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Circular RNAs (circRNAs) are a class of new-found RNA molecules that have a special covalent loop structure without a 5' cap and 3' tail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 756,
                    "text": "Emerging evidence shows that circRNAs play important roles in several diseases, particularly in cancer where they act through regulating protein expression of the pivotal genes that are critical for carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 287,
                    "offsetInEndSection": 443,
                    "text": "Functional circRNAs have been identified to act as microRNA sponges and RNA-binding protein (RBP) sequestering agents as well as transcriptional regulators."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 25,
                    "text": "Circular RNAs and cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "The understanding of circular RNAs as special triggers in carcinogenesis."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                "http://www.ncbi.nlm.nih.gov/pubmed/21801775",
                "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219461",
                "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                "http://www.ncbi.nlm.nih.gov/pubmed/15866516",
                "http://www.ncbi.nlm.nih.gov/pubmed/16805830",
                "http://www.ncbi.nlm.nih.gov/pubmed/11478915",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                "http://www.ncbi.nlm.nih.gov/pubmed/14759602"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 499,
                    "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 214,
                    "text": "The mainly neuronally expressed protein p42(IP4) (centaurin \u03b11; ADAP1), which interacts with the metalloendopeptidase nardilysin (NRD) was found to be localized in neuritic plaques in Alzheimer disease (AD) brains."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin \u03b1 1; ADAP1) in neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Nardilysin (NRDc), a metallopeptidase of the M16 family, presents, in vitro, cleavage specificity for basic residues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "The peptidase nardilysin is involved in degradation of neuropeptides and limited intracellular proteolysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 817,
                    "text": "Porcine mMDH, but not porcine cytosolic MDH, was shown to form a heterodimer with nardilysin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 936,
                    "text": "Mitochondrial MDH increased nardilysin activity about 50%, while nardilysin stabilized mMDH towards heat inactivation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16805830",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Interaction of the brain-specific protein p42IP4/centaurin-alpha1 with the peptidase nardilysin is regulated by the cognate ligands of p42IP4, PtdIns(3,4,5)P3 and Ins(1,3,4,5)P4, with stereospecificity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Gel filtration chromatography showed that nardilysin activity in a rat testis or rat brain extract exhibited an apparent molecular weight of approximately 300 kDa compared to approximately 187 kDa for the purified enzyme."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15866516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 645,
                    "offsetInEndSection": 773,
                    "text": "Thus, like insulysin and nardilysin, but contrary to bacterial pitrilysin, ppBH4 is inactivated by sulfhydryl alkylating agents."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                "http://www.ncbi.nlm.nih.gov/pubmed/16956501",
                "http://www.ncbi.nlm.nih.gov/pubmed/19831558",
                "http://www.ncbi.nlm.nih.gov/pubmed/18579028",
                "http://www.ncbi.nlm.nih.gov/pubmed/17158278",
                "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                "http://www.ncbi.nlm.nih.gov/pubmed/7747304",
                "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                "http://www.ncbi.nlm.nih.gov/pubmed/3592920"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 647,
                    "offsetInEndSection": 730,
                    "text": "Treatment of latent or active tuberculosis was recommended according to the result."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 733,
                    "offsetInEndSection": 899,
                    "text": "RESULTS\nSchool exposures were identified and underwent the Mantoux skin test (142 students in years 1, 2, 3, and 4 of compulsory secondary education and 22 teachers)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 36,
                    "text": "[Tuberculosis outbreak in a school]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 270,
                    "offsetInEndSection": 378,
                    "text": "SETTING\nThe Santa Maria de la Providencia school, located in the municipality of Alcala de Henares in Spain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 566,
                    "offsetInEndSection": 646,
                    "text": "Mantoux skin test and, if positive, chest radiograph were performed in contacts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1552,
                    "offsetInEndSection": 1631,
                    "text": "Latent tuberculosis treatment was recommended in all Mantoux-positive contacts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1379,
                    "offsetInEndSection": 1485,
                    "text": "In this second phase, 134 students received the Mantoux skin test and seven were Mantoux positive (5.2 %)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 238,
                    "text": "OBJECTIVE\nTo demonstrate the importance of preventive measures when a case of tuberculosis is detected, identify the causes that favored a tuberculosis outbreak in a school and determine the efficiency of obtaining induced sputum samples."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1113,
                    "offsetInEndSection": 1251,
                    "text": "A further two students, identified as contacts, were studied in another center and also started treatment for active tuberculosis disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 486,
                    "offsetInEndSection": 565,
                    "text": "Study of contacts in the collective was performed as a programmed intervention."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/28734077"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 292,
                    "text": "This card is not recommended for protein analyses, since surface treatment may denature proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The indicating FTA elute micro card\u2122 has been developed to collect and stabilize the nucleic acid in biological samples and is widely used in human and veterinary medicine and other disciplines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1038,
                    "text": "Our results demonstrate that samples applied to the indicating FTA elute micro card\u2122 are amendable to protein analyses, given that a sensitive protein detection assay is used."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card\u2122."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1039,
                    "offsetInEndSection": 1149,
                    "text": "The results imply that biological samples applied to FTA cards can be used for DNA, RNA and protein detection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 473,
                    "text": "We studied the ability to analyse proteins in human plasma and vaginal fluid as applied to the indicating FTA elute micro card\u2122 using the sensitive proximity extension assay (PEA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 862,
                    "text": "Liquid-based cytology samples showed a lower number of proteins above LOD than FTA cards with vaginal fluid samples applied."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 655,
                    "offsetInEndSection": 737,
                    "text": "Washing and protein elution protocols were compared to identify an optimal method."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                "http://www.ncbi.nlm.nih.gov/pubmed/10096530",
                "http://www.ncbi.nlm.nih.gov/pubmed/12777909",
                "http://www.ncbi.nlm.nih.gov/pubmed/12038658",
                "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973515"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1440,
                    "offsetInEndSection": 1635,
                    "text": "CONCLUSIONS\nThe authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for ischemic stroke in the model studied and, indeed, may significantly worsen stroke outcome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1284,
                    "offsetInEndSection": 1504,
                    "text": "CONCLUSIONS\nDoses of enlimomab between 140 and 480 mg administered over 5 days did not increase the risk of adverse events in patients with ischaemic or haemorrhagic stroke during an observation period of 30 +/- 10 days."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "BACKGROUND AND PURPOSE\nTo obtain information on the safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody) in stroke patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 384,
                    "text": "The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 329,
                    "offsetInEndSection": 498,
                    "text": "A loading dose of enlimomab administered within 24 h of the onset of stroke symptoms was followed by four daily maintenance doses; total doses ranged from 140 to 480 mg."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 546,
                    "text": "METHODS\nA total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 282,
                    "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1246,
                    "offsetInEndSection": 1361,
                    "text": "There were significantly more adverse events with enlimomab treatment than placebo, primarily infections and fever."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                "http://www.ncbi.nlm.nih.gov/pubmed/21880665",
                "http://www.ncbi.nlm.nih.gov/pubmed/19626133",
                "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                "http://www.ncbi.nlm.nih.gov/pubmed/27653967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28596937",
                "http://www.ncbi.nlm.nih.gov/pubmed/28510482",
                "http://www.ncbi.nlm.nih.gov/pubmed/25105153"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Treatment possibilities based on specific gene therapy strategies have become reality for a small number of patients with hereditary retinal dystrophies and are currently under investigation in several clinical trials worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 438,
                    "offsetInEndSection": 650,
                    "text": "Depending on the size of the gene copy to be transferred, two vectors are currently used in clinical trials: vectors based on adeno-associated virus (AAV) or on lentivirus (equine infectious anaemia virus, EIAV)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 285,
                    "offsetInEndSection": 530,
                    "text": "These novel gene vectors aim to more safely and efficiently transduce retinal cells, expand the gene packaging capacity of AAV, and utilize new strategies to correct the varying mechanisms of dysfunction found with inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1313,
                    "offsetInEndSection": 1495,
                    "text": "Our results provide important considerations for viral vectors to be used in future gene therapy clinical trials targeting a wider severity spectrum of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "BACKGROUND\nGene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 803,
                    "offsetInEndSection": 915,
                    "text": "This article gives an overview of the current state of specific gene therapy for hereditary retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 654,
                    "text": "Using this model, we evaluated if gene replacement therapy using recent advancements in adeno-associated viral vectors (AAV) provides advantages in preventing rapid retinal degeneration."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "[Specific gene therapy for hereditary retinal dystrophies - an update]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 834,
                    "text": "Here, we review immunity against AAV vector and transgene in the context of gene delivery specific to muscles for treating muscular dystrophies and non-muscle diseases in large animal models and human trials, factors that influence the intensity of the immune responses, and immune modulatory strategies to prevent unwanted immune responses and induce tolerance to the vector and therapeutic gene for a successful gene therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 437,
                    "text": "In addition, studies are ongoing for patients with disease causing mutations in the MERTK, REP1, ABCA4, or Myosin7A gene."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                "http://www.ncbi.nlm.nih.gov/pubmed/12468781",
                "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                "http://www.ncbi.nlm.nih.gov/pubmed/12365823",
                "http://www.ncbi.nlm.nih.gov/pubmed/9305321",
                "http://www.ncbi.nlm.nih.gov/pubmed/10582983"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1613,
                    "offsetInEndSection": 1727,
                    "text": "CONCLUSIONS\nThis systematic review supports some benefits of citicoline in the treatment of acute ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "The International Citicoline Trial in acUte Stroke is a sequential phase III study of the use of the drug citicoline in the treatment of acute ischaemic stroke, which was initiated in 2006 in 56 treatment centres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1908,
                    "offsetInEndSection": 2059,
                    "text": "INTERPRETATION\nUnder the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "This study was to evaluate the efficacy and safety of early application of citicoline in the treatment of patients with acute stroke by meta-analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 236,
                    "offsetInEndSection": 420,
                    "text": "This study aims to assess whether starting citicoline treatment within 14 days after stroke onset improves the outcome in patients with acute ischemic stroke, as compared with placebo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 279,
                    "text": "Previous safety and efficacy trials in patients who have had acute strokes suggested that citicoline may improve neurologic outcome with minimal side effects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 777,
                    "offsetInEndSection": 1015,
                    "text": "A meta-analysis of four randomized US clinical citicoline trials concluded that treatment with oral citicoline within the first 24 h after a moderate to severe stroke is safe and increases the probability of complete recovery at 3 months."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1701,
                    "offsetInEndSection": 1849,
                    "text": "CONCLUSIONS\nCiticoline was safe but ineffective in improving the outcome of patients with acute ischemic stroke as measured by the planned analyses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12468781",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 281,
                    "text": "Citicoline has been studied worldwide in many clinical trials with positive findings, but only 1 trial has obtained significant results in the primary efficacy variables."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                "http://www.ncbi.nlm.nih.gov/pubmed/24764069",
                "http://www.ncbi.nlm.nih.gov/pubmed/16023247",
                "http://www.ncbi.nlm.nih.gov/pubmed/20179655",
                "http://www.ncbi.nlm.nih.gov/pubmed/9119402",
                "http://www.ncbi.nlm.nih.gov/pubmed/7689553",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/8872612"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 987,
                    "text": "It appears therefore that the genes encoding lysyl oxidase and a lysyl oxidase-like protein share a common evolutionary origin and may also be functionally related."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 688,
                    "offsetInEndSection": 822,
                    "text": "Northern blot analysis also revealed the concomitant appearance of lysyl oxidase and lysyl oxidase-like mRNA in several human tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 297,
                    "offsetInEndSection": 488,
                    "text": "Restriction mapping and DNA sequence analysis revealed that the complete sequence of the lysyl oxidase-like mRNA was encoded by seven exons distributed throughout 25 kilobases of genomic DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 296,
                    "text": "Using one of these lysyl oxidase-like cDNAs, we obtained several overlapping genomic DNA recombinants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "We have isolated a number of recombinant clones from a human skin fibroblast cDNA library that contain extensive sequence homology to several coding domains within the human lysyl oxidase mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 153,
                    "text": "Lysyl oxidase like-2 (LOXL2) belongs to the lysyl oxidase (LOX) family, which comprises Cu(2+)- and lysine tyrosylquinone (LTQ)-dependent amine oxidases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9119402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 831,
                    "text": "An AluI restriction site polymorphism within intron 4 was used to map the mouse lysyl oxidase-like gene (Loxl) to mouse Chromosome 9 in a region that shares linkage conservation with human chromosome 15q24, to which the LOXL was recently mapped."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24764069",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1449,
                    "offsetInEndSection": 1562,
                    "text": "The level of lysyl oxidase-like 2 was significantly correlated with that of TGF-\u03b2, suggesting induction by TGF-\u03b2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7689553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 576,
                    "text": "This lysyl oxidase-like gene, which appears to be no larger than 22.1 kilobases, codes for a single polyadenylated RNA species of 2.48 kilobases and has been mapped to chromosome 15q24-q25."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                "http://www.ncbi.nlm.nih.gov/pubmed/26230285",
                "http://www.ncbi.nlm.nih.gov/pubmed/28798540",
                "http://www.ncbi.nlm.nih.gov/pubmed/25823874",
                "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                "http://www.ncbi.nlm.nih.gov/pubmed/27018280",
                "http://www.ncbi.nlm.nih.gov/pubmed/22675198",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/26990020"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1010,
                    "text": "CONCLUSIONS\nGDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Growth Differentiation Factor 15 as a Novel Biomarker for Metformin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 698,
                    "text": "RESULTS\nGrowth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 61,
                    "text": "OBJECTIVE\nMetformin is a commonly used glucose-lowering drug."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 860,
                    "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P < 0.0001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 62,
                    "offsetInEndSection": 159,
                    "text": "However, apart from glycemic measures, no biomarker for its presence or dose has been identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 374,
                    "text": "RESEARCH DESIGN AND METHODS\nA total of 237 biomarkers were assayed in baseline serum from 8,401 participants (2,317 receiving metformin) in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 375,
                    "offsetInEndSection": 444,
                    "text": "Regression models were used to identify biomarkers for metformin use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 773,
                    "text": "For the remaining 25 linked biomarkers, the odds ranged from 0.71 to 1.24."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                "http://www.ncbi.nlm.nih.gov/pubmed/22815318",
                "http://www.ncbi.nlm.nih.gov/pubmed/28243993",
                "http://www.ncbi.nlm.nih.gov/pubmed/28942404",
                "http://www.ncbi.nlm.nih.gov/pubmed/21247220",
                "http://www.ncbi.nlm.nih.gov/pubmed/28235209",
                "http://www.ncbi.nlm.nih.gov/pubmed/28164324",
                "http://www.ncbi.nlm.nih.gov/pubmed/25645999",
                "http://www.ncbi.nlm.nih.gov/pubmed/25499233"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 561,
                    "offsetInEndSection": 772,
                    "text": "Participants cited a range of etiologies and overlapping conditions including asthma, Reactive Airway Dysfunction Syndrome (RADS), Sick Building Syndrome (SBS), Chronic Fatigues Syndrome (CFS), and Fibromyalgia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 253,
                    "offsetInEndSection": 395,
                    "text": "Recently, however, tumor lysis syndrome (TLS) resulting from rituximab has been reported in a patient with chronic lymphocytic leukemia (CLL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of low-grade or follicular non-Hodgkin's lymphoma (NHL)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 773,
                    "offsetInEndSection": 865,
                    "text": "Physicians infrequently considered chemicals as a cause of illness when seeing new patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 252,
                    "text": "Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 319,
                    "text": "Survey questions addressed demographics; familiarity with MCS; etiology; overlapping conditions; accommodations made for patients and practices regarding evaluation, treatment, and referral."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 378,
                    "offsetInEndSection": 560,
                    "text": "Under a third had received any medical training regarding chemical sensitivity, only 7% were \"very satisfied\" with their knowledge, and 6% had a treatment protocol for the condition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815318",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "The primary objective was to evaluate the response rate of rituximab therapy for children with chronic immune thrombocytopenic purpura (ITP) and Evans syndrome (ES) and immune reconstitution of these children after rituximab therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Ninety physicians practicing in the state of Virginia USA completed a mail survey regarding Multiple Chemical Sensitivity (MCS)."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                "http://www.ncbi.nlm.nih.gov/pubmed/28073589",
                "http://www.ncbi.nlm.nih.gov/pubmed/26292731",
                "http://www.ncbi.nlm.nih.gov/pubmed/24845676",
                "http://www.ncbi.nlm.nih.gov/pubmed/21529715",
                "http://www.ncbi.nlm.nih.gov/pubmed/20098673",
                "http://www.ncbi.nlm.nih.gov/pubmed/25621662",
                "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                "http://www.ncbi.nlm.nih.gov/pubmed/20454618"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 492,
                    "text": "Aberrant oncogene expression induces replication stress, leading to DNA breaks and genomic instability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 140,
                    "offsetInEndSection": 296,
                    "text": "Among these regions are fragile sites (FSs), genomic regions sensitive to replication stress conditions induced by the DNA polymerase inhibitor aphidicolin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 931,
                    "offsetInEndSection": 1148,
                    "text": "Consequently, we reveal that increased transcription can be a mechanism of oncogene-induced DNA damage, providing a molecular link between upregulation of the transcription machinery and genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 766,
                    "offsetInEndSection": 930,
                    "text": "Furthermore, overexpression of TBP alone causes the hallmarks of oncogene-induced replication stress, including replication fork slowing, DNA damage and senescence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 698,
                    "offsetInEndSection": 806,
                    "text": "Oncogene-induced FSs colocalize with cancer breakpoints and large genes, similar to aphidicolin-induced FSs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 493,
                    "offsetInEndSection": 697,
                    "text": "Here we map the cytogenetic locations of oncogene-induced FSs and show that in the same cells, each oncogene creates a unique fragility landscape that only partially overlaps with aphidicolin-induced FSs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24845676",
                    "endSection": "abstract",
                    "offsetInBeginSection": 639,
                    "offsetInEndSection": 908,
                    "text": "Here, we review our current understanding of replication initiation and its regulation, describe mechanisms by which activated oncogenes might interfere with these processes and discuss how replicative stress might contribute to the genomic instability seen in cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1228,
                    "text": "Comparative genomic hybridization analysis of stem cells derived by these protocols revealed the presence of genomic deletions and amplifications, whose signature was suggestive of oncogene-induced DNA replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Recurrent genomic instability in cancer is attributed to positive selection and/or the sensitivity of specific genomic regions to breakage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 297,
                    "offsetInEndSection": 388,
                    "text": "However, the basis for the majority of cancer genomic instability hotspots remains unclear."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                "http://www.ncbi.nlm.nih.gov/pubmed/26595274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                "http://www.ncbi.nlm.nih.gov/pubmed/26081994",
                "http://www.ncbi.nlm.nih.gov/pubmed/25231926",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493899",
                "http://www.ncbi.nlm.nih.gov/pubmed/10871390",
                "http://www.ncbi.nlm.nih.gov/pubmed/20229501"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1341,
                    "offsetInEndSection": 1462,
                    "text": "Lastly, we show that petrous bones from ancient cremated individuals contain no measurable levels of authentic human DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1151,
                    "offsetInEndSection": 1340,
                    "text": "Interestingly, we observe signficantly higher levels of cytosine to thymine deamination damage and lower proportions of mitochondrial/nuclear DNA in petrous bone compared to tooth cementum."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 617,
                    "text": "Both substrates display significantly higher endogenous DNA content (average of 16.4% and 40.0% for teeth and petrous bones, respectively) than parietal skull bone (average of 2.2%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 890,
                    "text": "In this study we investigate whether (a) different parts of the petrous bone of archaeological human specimens give different percentages of endogenous DNA yields, (b) there are significant differences in average DNA read lengths, damage patterns and total DNA concentration, and (c) it is possible to obtain endogenous ancient DNA from petrous bones from hot environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 255,
                    "text": "The inner part of petrous bones and the cementum layer in teeth roots are currently recognized as the best substrates for such research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 495,
                    "text": "The osseous labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the cranial vault or base."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 943,
                    "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                "http://www.ncbi.nlm.nih.gov/pubmed/11269499",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                "http://www.ncbi.nlm.nih.gov/pubmed/9111348",
                "http://www.ncbi.nlm.nih.gov/pubmed/16314266",
                "http://www.ncbi.nlm.nih.gov/pubmed/17189193",
                "http://www.ncbi.nlm.nih.gov/pubmed/19683670",
                "http://www.ncbi.nlm.nih.gov/pubmed/25800735"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "abstract",
                    "offsetInBeginSection": 844,
                    "offsetInEndSection": 1029,
                    "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1038,
                    "offsetInEndSection": 1226,
                    "text": "Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 364,
                    "text": "We present bioinformatic, phylogenetic, and experimental evidence in Drosophila for a mechanism that subdivides many large introns by recursive splicing at nonexonic elements and alternative exons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1253,
                    "text": "Experimental analyses of in vivo processing intermediates and lariat products from four large introns in the unrelated genes kuzbanian, outspread, and Ultrabithorax confirmed that these introns are removed by a series of recursive splicing steps using the predicted nonexonic sites."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1030,
                    "offsetInEndSection": 1218,
                    "text": "Still, the very existence and widespread nature of recursive splicing offers a new regulatory layer in the transcript maturation pathway, which may also have implications in human disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 310,
                    "text": "However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 562,
                    "offsetInEndSection": 709,
                    "text": "The sequential nature of recursive splicing was confirmed by identification of lariat introns generated by splicing to and from the ratchet points."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 922,
                    "text": "We also show that recursive splicing is a constitutive process, that depletion of U2AF inhibits recursive splicing, and that the sequence and function of ratchet points are evolutionarily conserved in Drosophila."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12918034",
                "http://www.ncbi.nlm.nih.gov/pubmed/8116",
                "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                "http://www.ncbi.nlm.nih.gov/pubmed/2875077",
                "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                "http://www.ncbi.nlm.nih.gov/pubmed/7911384",
                "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                "http://www.ncbi.nlm.nih.gov/pubmed/2859144",
                "http://www.ncbi.nlm.nih.gov/pubmed/26612622",
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Lysyl oxidase catalyzes the formation of crosslinking aldehydes in collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 777,
                    "text": "These data indicate that although skin lysyl oxidase activity is decreased by glucocorticoid treatment, the crosslinking of acid extracted collagen as measured by the alpha/beta ratio and collagen solubility is increased."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 361,
                    "text": "In this study, we utilized lysyl oxidase (LO) to enzymatically crosslink extracellular matrix (ECM) proteins, particularly collagen and elastin, to enhance the mechanical integrity of the ECM and thereby impart mechanical strength to the engineered tissue."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Skin lysyl oxidase activity is not rate limiting for collagen crosslinking in the glucocorticoid-treated rat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 480,
                    "text": "The enzyme lysyl oxidase which catalyses the aldehyde formation in certain lysyl residues of collagen and elastin was extracted from the skin of hypophysectomized rats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034",
                    "endSection": "abstract",
                    "offsetInBeginSection": 857,
                    "offsetInEndSection": 1098,
                    "text": "When smooth muscle cells transfected with lysyl oxidase were seeded in collagen gels, the tensile strength and elastic modulus in these constructs increased by approximately two-fold compared to constructs seeded with mock-transfected VSMCs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 650,
                    "offsetInEndSection": 817,
                    "text": "The result showed that the aldehyde deficient collagen did not crosslink while in the hypophysectomized animal indicating the lack of active lysyl oxidase in the rats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Biosynthesis of collagen crosslinks: increased activity of purified lysyl oxidase with reconstituted collagen fibrils."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Lysyl oxidase catalyzes the crosslinking of collagen and elastin."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                "http://www.ncbi.nlm.nih.gov/pubmed/17244925",
                "http://www.ncbi.nlm.nih.gov/pubmed/16967378",
                "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                "http://www.ncbi.nlm.nih.gov/pubmed/20494064",
                "http://www.ncbi.nlm.nih.gov/pubmed/23989817",
                "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                "http://www.ncbi.nlm.nih.gov/pubmed/15854093",
                "http://www.ncbi.nlm.nih.gov/pubmed/25332648",
                "http://www.ncbi.nlm.nih.gov/pubmed/12543579"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "OBJECTIVES\nTo determine the difference in sternal infection and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 433,
                    "text": "METHODS\nThe sternal ZipFix\u2122 (ZF) system consists of a biocompatible poly-ether-ether-ketone (PEEK) cable-tie that surrounds the sternum through the intercostal space and provides a large implant-to-bone contact."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1671,
                    "offsetInEndSection": 1791,
                    "text": "CONCLUSIONS\nOur study underlines a neutral effect of the sternal ZipFix\u2122 system in patients regarding sternal infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1100,
                    "offsetInEndSection": 1286,
                    "text": "Comparing ZF with CW with regard to sternal infection, there is no statistically significant difference related to the device (odds ratio: 0.067, confidence interval: 0.04-9.16, P=0.72)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "A new cable-tie-based sternal closure device: infectious considerations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1865,
                    "offsetInEndSection": 1932,
                    "text": "The cable-tie-based system is fast, easy to use, reliable and safe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1099,
                    "text": "RESULTS\nTotal infection rate was 6.1%, with a total of 36 diagnosed sternal infections (5 in ZF and 31 in CW)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 551,
                    "text": "Between 1 February 2011 and 31 January 2012, 680 cardiac operations were performed via sternotomy at our institution."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1466,
                    "offsetInEndSection": 1559,
                    "text": "No sternal instability was observed with the ZF device, unlike 4/31 patients in the CW group."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 789,
                    "text": "After the exclusion of operations for active endocarditis and early mortality within 7 days, 95 patients were exclusively closed with ZF and could be compared with 498 who were closed with conventional wires (CWs) during the same period."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                "http://www.ncbi.nlm.nih.gov/pubmed/25561718",
                "http://www.ncbi.nlm.nih.gov/pubmed/25810254",
                "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                "http://www.ncbi.nlm.nih.gov/pubmed/24909122",
                "http://www.ncbi.nlm.nih.gov/pubmed/24778216",
                "http://www.ncbi.nlm.nih.gov/pubmed/23636943",
                "http://www.ncbi.nlm.nih.gov/pubmed/25263592",
                "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                "http://www.ncbi.nlm.nih.gov/pubmed/27066865"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 405,
                    "offsetInEndSection": 608,
                    "text": "Here we report that in human breast cancer cells 17\u03b2-oestradiol (E2)-bound oestrogen receptor \u03b1 (ER-\u03b1) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 94,
                    "offsetInEndSection": 289,
                    "text": "In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 740,
                    "offsetInEndSection": 967,
                    "text": "This enhancer exhibits intimately linked virus-inducible enhancer and bidirectional promoter activity that is largely dependent on a conserved Interferon Stimulated Response Element and robustly generates virus inducible eRNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 210,
                    "offsetInEndSection": 300,
                    "text": "However, it remains unclear how tightly coupled eRNA production is with enhancer activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 596,
                    "text": "Instead, communication between promoters and enhancers can be bidirectional with promoters required to activate enhancer transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 433,
                    "offsetInEndSection": 833,
                    "text": "The distal enhancer of the gonadotropin hormone \u03b1-subunit gene, chorionic gonadotropin alpha (Cga), is responsible for Cga cell-specific expression in gonadotropes and thyrotropes, and we show here that it encodes two bidirectional nonpolyadenylated RNAs whose levels are increased somewhat by exposure to gonadotropin-releasing hormone but are not necessarily linked to Cga transcriptional activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 597,
                    "offsetInEndSection": 709,
                    "text": "Reciprocally, eRNAs may then facilitate enhancer-promoter interaction or activate promoter-driven transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1062,
                    "offsetInEndSection": 1161,
                    "text": "We demonstrate that the interaction of the enhancer with the promoter is lost after eRNA knockdown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 968,
                    "offsetInEndSection": 1118,
                    "text": "Notably, its enhancer and promoter activities are fully retained in reporter assays even upon a complete elimination of its associated eRNA sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1060,
                    "offsetInEndSection": 1177,
                    "text": "Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                "http://www.ncbi.nlm.nih.gov/pubmed/23031510",
                "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115162",
                "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                "http://www.ncbi.nlm.nih.gov/pubmed/8223640",
                "http://www.ncbi.nlm.nih.gov/pubmed/8725011",
                "http://www.ncbi.nlm.nih.gov/pubmed/28715909"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 398,
                    "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 521,
                    "text": "In archaea, aPelota and aEF1\u03b1, homologous to Pelota and Hbs1, respectively, are considered to be involved in that process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 270,
                    "text": "Then, ribosomes are rescued from the aberrant mRNA, and the aberrant mRNA is subsequently degraded."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 170,
                    "text": "However, when ribosomes translate an aberrant mRNA, they stall."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 788,
                    "text": "A Drosophila homolog of Dom34p, pelota, is required for the proper coordination of meiosis and spermatogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "In the translation process, translating ribosomes usually move on an mRNA until they reach the stop codon."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Recent structural studies on Dom34/aPelota and Hbs1/aEF1\u03b1: important factors for solving general problems of ribosomal stall in translation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "abstract",
                    "offsetInBeginSection": 318,
                    "offsetInEndSection": 448,
                    "text": "RPS30A, which encodes ribosomal protein S30, was identified in a screen for high-copy suppressors of the dom34delta growth defect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 627,
                    "offsetInEndSection": 771,
                    "text": "In this review, we focus on the functional roles of Dom34/aPelota and Hbs1/aEF1\u03b1 in ribosome rescue, based on recent structural studies of them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "abstract",
                    "offsetInBeginSection": 789,
                    "offsetInEndSection": 979,
                    "text": "Heterologous expression of pelota in dom34delata mutants restores wild-type growth and differentiation, suggesting conservation of function between the eukaryotic members of the gene family."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                "http://www.ncbi.nlm.nih.gov/pubmed/26283469",
                "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                "http://www.ncbi.nlm.nih.gov/pubmed/23009808",
                "http://www.ncbi.nlm.nih.gov/pubmed/16412049",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
                "http://www.ncbi.nlm.nih.gov/pubmed/26233476"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Chondrogenic differentiation of human mesenchymal stem cells in micro-masses is impaired by high doses of the chemokine CXCL7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 802,
                    "text": "Solution nuclear magnetic resonance (NMR) and molecular dynamics characterization of platelet-derived chemokine CXCL7 heterodimerization with chemokines CXCL1, CXCL4, and CXCL8 indicated that packing interactions promote CXCL7-CXCL1 and CXCL7-CXCL4 heterodimers, and electrostatic repulsive interactions disfavor the CXCL7-CXCL8 heterodimer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1377,
                    "offsetInEndSection": 1576,
                    "text": "Pathway analysis suggests that recruitment of human MSC by CXCL7 is supported by the induction of ligands of the interleukin 8 receptors, synergistically activating the respective signaling pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26233476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 267,
                    "text": "Levels of CXC chemokine ligand 7 (CXCL7) protein vary during tumorigenesis, and the evidence suggests that this chemokine serves as a novel biomarker of early-stage lung cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Many cells, including leucocytes and stromal cells, express CXCL7, a member of the CXC chemokine family, also known as platelet basic protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                    "endSection": "abstract",
                    "offsetInBeginSection": 687,
                    "offsetInEndSection": 930,
                    "text": "Pathway analysis showed that CXCL7 induced the expression of all chemokines binding the interleukin (IL) receptors A and B, CXCR1 and CXCR2, as well as the IL6 signal transducer (gp130) and its ligands IL6 and leukemia inhibitory factor (LIF)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 214,
                    "text": "CXCL7 is a potent chemoattractant and activator of neutrophil function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 977,
                    "offsetInEndSection": 1171,
                    "text": "NMR and modeling studies indicated that GAG heparin binding to the heterodimer is distinctly different from the CXCL7 monomer and that the GAG-bound heterodimer is unlikely to bind the receptor."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                "http://www.ncbi.nlm.nih.gov/pubmed/24413888",
                "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                "http://www.ncbi.nlm.nih.gov/pubmed/23325252",
                "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                "http://www.ncbi.nlm.nih.gov/pubmed/29421284",
                "http://www.ncbi.nlm.nih.gov/pubmed/15708008",
                "http://www.ncbi.nlm.nih.gov/pubmed/27616276",
                "http://www.ncbi.nlm.nih.gov/pubmed/18503142"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The effects of hydrated C(60) fullerene on gene expression profile of TRPM2 and TRPM7 in hyperhomocysteinemic mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 609,
                    "offsetInEndSection": 733,
                    "text": "TRPM2 and TRPM7 gene expression in brains of mice were detected by real-time PCR, Western blotting and immunohistochemistry."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 326,
                    "offsetInEndSection": 454,
                    "text": "We aimed to examine the effects on TRPM2 and TRPM7 gene expression of C(60)HyFn due to marked antioxidant activity in HHcy mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 86,
                    "offsetInEndSection": 190,
                    "text": "Transient receptor potential melastatin (TRPM2) and TRPM7 channels may be activated by oxidative stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 510,
                    "text": "Here, we report that one such long non-coding RNA, TRPM2-AS, an antisense transcript of TRPM2, which encodes an oxidative stress-activated ion channel, is overexpressed in prostate cancer (PCa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "BACKGROUND\nHyperhomocysteinemia (HHcy) is associated with neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1279,
                    "offsetInEndSection": 1422,
                    "text": "Increased expression level of TRPM2 induced by oxidative stress might be involved in the ethiopathogenesis of HHcy related neurologic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 715,
                    "offsetInEndSection": 1012,
                    "text": "Mechanistically, TRPM2-AS knockdown led to PCa cell apoptosis, with a transcriptional profile that indicated an unbearable increase in cellular stress in the dying cells, which was coupled to cell cycle arrest, an increase in intracellular hydrogen peroxide and activation of the sense TRPM2 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1124,
                    "offsetInEndSection": 1278,
                    "text": "CONCLUSION\nAdministration of C(60)HyFn in HHcy mice significantly reduces serum homocysteine level, neuronal apoptosis and expression level of TRPM2 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24413888",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1260,
                    "text": "Therefore, we conclude that TRPM2 mediates the LPA-induced suppression of axonal growth, which provides a long-sought mechanism underlying the effect of LPA on neuronal development."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                "http://www.ncbi.nlm.nih.gov/pubmed/27355570",
                "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                "http://www.ncbi.nlm.nih.gov/pubmed/28328129",
                "http://www.ncbi.nlm.nih.gov/pubmed/27544075",
                "http://www.ncbi.nlm.nih.gov/pubmed/27228275",
                "http://www.ncbi.nlm.nih.gov/pubmed/27647195",
                "http://www.ncbi.nlm.nih.gov/pubmed/27876396"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "A recent outbreak of Zika virus (ZIKV) in Brazil is associated with microcephaly in infants born of infected mothers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1212,
                    "text": "The expression of premembrane protein (prM) resulted in cell-cycle G1 accumulation, whereas membrane-anchored capsid (anaC), membrane protein (M), envelope protein (E), and nonstructural protein 4A (NS4A) caused cell-cycle G2/M accumulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 548,
                    "text": "They demonstrated cytopathogenic activity for seven ZIKV proteins, anaC, C, prM, M, E, NS2B and NS4A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 525,
                    "text": "In this analysis we provide an overview of both microcephaly and ZIKV, explore the connection between prenatal ZIKV infection and microcephaly, and highlight recent insights into how prenatal ZIKV infection depletes the pool of neural progenitors in the developing brain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 558,
                    "text": "Here we show that a single serine-to-asparagine substitution [Ser139\u2192Asn139 (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Accumulating evidence implicates Zika virus (ZIKV) in pathogenesis of microcephaly in newborns and Guillain-Barr\u00e9 syndrome in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 253,
                    "text": "As this pandemic spreads, rapid scientific investigation is shedding new light on how prenatal infection with ZIKV causes microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 285,
                    "text": "However, it remains unclear which viral proteins are responsible for these effects and what are the underlying mechanisms of their pathogenic activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                "http://www.ncbi.nlm.nih.gov/pubmed/19883199",
                "http://www.ncbi.nlm.nih.gov/pubmed/18316014",
                "http://www.ncbi.nlm.nih.gov/pubmed/23575186",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822120",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228241",
                "http://www.ncbi.nlm.nih.gov/pubmed/27339659",
                "http://www.ncbi.nlm.nih.gov/pubmed/8360667",
                "http://www.ncbi.nlm.nih.gov/pubmed/12851054"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 307,
                    "offsetInEndSection": 473,
                    "text": "These subsets were filtered against disease-related variants in the ClinVar, UniProtKB/Swiss-Prot, and PhenCode databases, to identify neutral or nonpathogenic cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "PhenCode (Phenotypes for ENCODE; http://www.bx.psu.edu/phencode) is a collaborative, exploratory project to help understand phenotypes of human mutations in the context of sequence and functional data from genome projects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 594,
                    "text": "All variant descriptions include mapping to reference sequences on chromosomal, genomic, coding DNA, and protein levels."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "VariSNP, a benchmark database for variations from dbSNP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 306,
                    "text": "VariSNP datasets are selected from dbSNP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 595,
                    "offsetInEndSection": 729,
                    "text": "The datasets will be updated with automated scripts on a regular basis and are freely available at http://structure.bmc.lu.se/VariSNP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 264,
                    "text": "Some previously developed datasets are available for this purpose, but newer and larger benchmark sets for benign variants have largely been missing."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "PhenCode: connecting ENCODE data with mutations and phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "For development and evaluation of methods for predicting the effects of variations, benchmark datasets are needed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 462,
                    "offsetInEndSection": 844,
                    "text": "Initially, we focused on a few selected LSDBs covering genes encoding alpha- and beta-globins (HBA, HBB), phenylalanine hydroxylase (PAH), blood group antigens (various genes), androgen receptor (AR), cystic fibrosis transmembrane conductance regulator (CFTR), and Bruton's tyrosine kinase (BTK), but we plan to include additional loci of clinical importance, ultimately genomewide."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                "http://www.ncbi.nlm.nih.gov/pubmed/8149615",
                "http://www.ncbi.nlm.nih.gov/pubmed/27713570",
                "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                "http://www.ncbi.nlm.nih.gov/pubmed/15362956",
                "http://www.ncbi.nlm.nih.gov/pubmed/25538045",
                "http://www.ncbi.nlm.nih.gov/pubmed/18633320",
                "http://www.ncbi.nlm.nih.gov/pubmed/28345086",
                "http://www.ncbi.nlm.nih.gov/pubmed/19950647"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1156,
                    "offsetInEndSection": 1363,
                    "text": "Applying SP3 toward the characterization of the proteome of FACS-sorted tumor-associated macrophages in the B16 tumor model enabled the quantification of 2965 proteins and revealed a \"mixed\" M1/M2 phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1330,
                    "text": "Together, the findings of this work position SP3 as a superior protocol that facilitates exciting new directions in multiple areas of proteomics ranging from developmental biology to clinical applications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 347,
                    "text": "Here, we performed an independent comparison between single-pot solid-phase-enhanced sample preparation (SP3), filter-aided sample preparation (FASP), and a commercial kit based on the in-StageTip (iST) method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Efficient and reproducible sample preparation is a prerequisite for any robust and sensitive quantitative bottom-up proteomics workflow."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 927,
                    "text": "To illustrate these benefits, characterization of 1,000 HeLa cells and single Drosophila embryos is used to establish that SP3 provides an enhanced platform for profiling proteomes derived from sub-microgram amounts of material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 770,
                    "offsetInEndSection": 852,
                    "text": "In contrast, SP3 and iST provided high proteome coverage even in the low \u03bcg range."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1008,
                    "offsetInEndSection": 1155,
                    "text": "On average, the quantitative reproducibility between experimental replicates was slightly higher in case of SP3 (R2 = 0.97 (SP3); R2 = 0.93 (iST))."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 460,
                    "offsetInEndSection": 698,
                    "text": "SP3 provides a rapid and unbiased means of proteomic sample preparation in a single tube that facilitates ultrasensitive analysis by outperforming existing protocols in terms of efficiency, scalability, speed, throughput, and flexibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 588,
                    "offsetInEndSection": 769,
                    "text": "When handling sample sizes below 10 \u03bcg, the number of identified proteins and peptides as well as the quantitative reproducibility and precision drastically dropped in case of FASP."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19457372",
                "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                "http://www.ncbi.nlm.nih.gov/pubmed/22516255",
                "http://www.ncbi.nlm.nih.gov/pubmed/27856734",
                "http://www.ncbi.nlm.nih.gov/pubmed/17643367",
                "http://www.ncbi.nlm.nih.gov/pubmed/28486100",
                "http://www.ncbi.nlm.nih.gov/pubmed/28368102",
                "http://www.ncbi.nlm.nih.gov/pubmed/11094257",
                "http://www.ncbi.nlm.nih.gov/pubmed/25758402"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 476,
                    "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 880,
                    "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19457372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1321,
                    "offsetInEndSection": 1536,
                    "text": "Moreover, they reveal different time courses of hijacking effects in ventrolateral and dorsolateral prefrontal regions, consistent with models in which these regions make distinct contributions to cognitive control."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19457372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1128,
                    "offsetInEndSection": 1320,
                    "text": "These findings show that consciously perceived, irrelevant instructional cues can activate inappropriate task objectives in working memory, resulting in a hijacking of the attentional network."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1131,
                    "text": "Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 737,
                    "offsetInEndSection": 902,
                    "text": "Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1088,
                    "text": "Recurrent tandem duplications intersecting with a TAD boundary mediate de novo formation of a 3D contact domain comprising IGF2 and a lineage-specific super-enhancer, resulting in high-level gene activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19457372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 512,
                    "offsetInEndSection": 864,
                    "text": "Using a cross-modal attentional cueing task in combination with functional magnetic resonance imaging, we found that such irrelevant cues can indeed hijack the attentional network, as indexed by increased activity in (a) frontal regions that control attention and (b) sensory cortices that underlie the perceptual processing of task-irrelevant stimuli."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/134458",
                "http://www.ncbi.nlm.nih.gov/pubmed/10970362",
                "http://www.ncbi.nlm.nih.gov/pubmed/14615789",
                "http://www.ncbi.nlm.nih.gov/pubmed/10938522",
                "http://www.ncbi.nlm.nih.gov/pubmed/8859279",
                "http://www.ncbi.nlm.nih.gov/pubmed/26413063",
                "http://www.ncbi.nlm.nih.gov/pubmed/7742235",
                "http://www.ncbi.nlm.nih.gov/pubmed/24739076",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                "http://www.ncbi.nlm.nih.gov/pubmed/19570075"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/134458",
                    "endSection": "abstract",
                    "offsetInBeginSection": 681,
                    "offsetInEndSection": 851,
                    "text": "In dermatophytoses, tinea corporis (49-71%) and tinea cruris (47-85%) commonest; tinea axillaris (3-42%), tinea capitis (1-72%) and tinea barbae (1-29%) were less common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/134458",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1459,
                    "offsetInEndSection": 1553,
                    "text": "From mycetoma, Madurella mycetomii, Nocardia braziliensis, N. asteroides and Actinomadura spp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26413063",
                    "endSection": "abstract",
                    "offsetInBeginSection": 501,
                    "offsetInEndSection": 595,
                    "text": "Tinea capitis was the most common clinical disease followed by tinea pedis and tinea corporis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7742235",
                    "endSection": "abstract",
                    "offsetInBeginSection": 678,
                    "offsetInEndSection": 797,
                    "text": "As newer antifungal agents are developed, more effective and convenient therapy for tinea capitis may become available."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 869,
                    "offsetInEndSection": 924,
                    "text": "Tinea unguium is regarded as one type of onychomycosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24739076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "BACKGROUND\nTinea pedis is a commonly encountered dermatophytic infection with a clinical prevalence of 15-25%."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/134458",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 456,
                    "text": "Dermatophytoses were found in 73-5%; the other common diseases were tinea versicolor (17-68%) and candidiasis (12-43%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7742235",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Tinea capitis caused by Trichophyton tonsurans is a common infection in children, and has become a significant public health problem in the United States."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/134458",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1236,
                    "offsetInEndSection": 1293,
                    "text": "Cutaneous candidiasis was mainly a problem of housewives."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/134458",
                    "endSection": "abstract",
                    "offsetInBeginSection": 940,
                    "offsetInEndSection": 1060,
                    "text": "High temperature and humidity were related to the higher incidence of tinea corporis, tinea cruris and tinea versicolor."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                "http://www.ncbi.nlm.nih.gov/pubmed/19484265",
                "http://www.ncbi.nlm.nih.gov/pubmed/8695862",
                "http://www.ncbi.nlm.nih.gov/pubmed/21504705",
                "http://www.ncbi.nlm.nih.gov/pubmed/9462544",
                "http://www.ncbi.nlm.nih.gov/pubmed/11252005",
                "http://www.ncbi.nlm.nih.gov/pubmed/12297986",
                "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                "http://www.ncbi.nlm.nih.gov/pubmed/11001932"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "The albino-deletion complex of the mouse: molecular mapping of deletion breakpoints that define regions necessary for development of the embryonic and extraembryonic ectoderm."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 615,
                    "offsetInEndSection": 782,
                    "text": "Similarly, the c11DSD breakpoints were isolated by cloning a c11DSD EcoRI fragment detected by a unique-sequence probe mapping proximal to the albino-coat-color locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 473,
                    "offsetInEndSection": 614,
                    "text": "The c2YPSj breakpoints were isolated by cloning an EcoRI fragment containing a copy of an albino region-specific repeat unique to c2YPSj DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 783,
                    "offsetInEndSection": 1099,
                    "text": "By mapping the cloned breakpoints relative to the remaining three deletions, the c11DSD distal breakpoint was found to define the distal limit of the region containing eed, whereas the c2YPSj and c6H distal breakpoints were found to define the proximal and distal limits, respectively, of the region containing exed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 313,
                    "text": "Previous complementation analyses with five (c11DSD, c5FR60Hg, c2YPSj, c4FR60Hd, c6H) of the mouse albino deletions defined at least two genes on chromosome 7, known as eed and exed, which are necessary for development of the embryonic and extraembryonic ectoderm, respectively, of early postimplantation embryos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 314,
                    "offsetInEndSection": 472,
                    "text": "The region of chromosome 7 containing these two genes has now been accessed at the molecular level by cloning two of the deletion breakpoint-fusion fragments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1465,
                    "text": "Therefore, the Fah gene maps within or proximal to the hsdr-1 locus, as defined by deletion breakpoints, and disruption of this gene may be partially or completely responsible for the phenotypes associated with the hsdr-1 deletion syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                    "endSection": "abstract",
                    "offsetInBeginSection": 930,
                    "offsetInEndSection": 1126,
                    "text": "In addition, the distal breakpoints of two viable albino deletions, which remove part of the tyrosinase gene and extend distally, were localized in the vicinity of the lethal deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 372,
                    "text": "By sequence-tagged site (STS) content mapping, we roughly defined deletion breakpoints in two unrelated, azoospermic men with AZFa deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19484265",
                    "endSection": "abstract",
                    "offsetInBeginSection": 322,
                    "offsetInEndSection": 603,
                    "text": "We have cloned 23 breakpoint junctions for a total of 46 breakpoints in 17 childhood ALL (9 B- and 8 T-lineages) showing different size deletions at one or both homologous chromosomes 9 to investigate which particular sequences make the region susceptible to interstitial deletion."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                "http://www.ncbi.nlm.nih.gov/pubmed/22361292",
                "http://www.ncbi.nlm.nih.gov/pubmed/25441720",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630241",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                "http://www.ncbi.nlm.nih.gov/pubmed/23489294",
                "http://www.ncbi.nlm.nih.gov/pubmed/26975529",
                "http://www.ncbi.nlm.nih.gov/pubmed/20940252"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 850,
                    "offsetInEndSection": 1040,
                    "text": "Our findings indicate that RBPs HuR and GRSF1 govern the cytoplasmic and mitochondrial localization of the lncRNA RMRP, which is encoded by nuclear DNA but has key functions in mitochondria."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 863,
                    "text": "Mutational analyses indicated that nuclear localization of BORG was mediated through a novel RNA motif consisting of the pentamer sequence AGCCC with sequence restrictions at positions -8 (T or A) and -3 (G or C) relative to the first nucleotide of the pentamer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 864,
                    "offsetInEndSection": 1092,
                    "text": "Mutation of the motif to a scrambled sequence resulted in complete loss of nuclear localization, while addition of even a single copy of the motif to a cytoplasmically localized RNA was sufficient to impart nuclear localization."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 440,
                    "text": "Using affinity RNA pull-down followed by mass spectrometry analysis, we found two RNA-binding proteins (RBPs), HuR (human antigen R) and GRSF1 (G-rich RNA sequence-binding factor 1), that associated with the nuclear DNA-encoded lncRNA RMRP and mobilized it to mitochondria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1093,
                    "offsetInEndSection": 1300,
                    "text": "Further, the presence of this motif in other cellular RNAs showed a direct correlation with nuclear localization, suggesting that the motif may act as a general nuclear localization signal for cellular RNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 788,
                    "offsetInEndSection": 1067,
                    "text": "To address whether localization of the lncRNA influences susceptibility to degradation by either ASOs or RNAi, nuclear lncRNAs (MALAT1 and NEAT1), cytoplasmic lncRNAs (DANCR and OIP5-AS1) and dual-localized lncRNAs (TUG1, CasC7 and HOTAIR) were compared for knockdown efficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "RNA, including long noncoding RNA (lncRNA), is known to be an abundant and important structural component of the nuclear matrix."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28846090",
                "http://www.ncbi.nlm.nih.gov/pubmed/26656845",
                "http://www.ncbi.nlm.nih.gov/pubmed/27789702",
                "http://www.ncbi.nlm.nih.gov/pubmed/28075484",
                "http://www.ncbi.nlm.nih.gov/pubmed/28723572",
                "http://www.ncbi.nlm.nih.gov/pubmed/27146274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28704389",
                "http://www.ncbi.nlm.nih.gov/pubmed/24097267",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                "http://www.ncbi.nlm.nih.gov/pubmed/28138849"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846090",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "We present Omni-ATAC, an improved ATAC-seq protocol for chromatin accessibility profiling that works across multiple applications with substantial improvement of signal-to-background ratio and information content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484",
                    "endSection": "abstract",
                    "offsetInBeginSection": 248,
                    "offsetInEndSection": 471,
                    "text": "have developed a rapid method, requiring low numbers of living cells as input, for examining chromatin accessibility across the epigenome, known as the assay for transposase-accessible chromatin using sequencing (ATAC-seq)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28723572",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1090,
                    "offsetInEndSection": 1256,
                    "text": "Thus, FANS-assisted ATAC-seq using transgenic zebrafish embryos provides a robust approach for genome-wide identification of active tissue-specific enhancer elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 767,
                    "text": "We illustrate how RASQUAL can be used to maximize association detection by generating the first map of chromatin accessibility QTLs (caQTLs) in a European population using ATAC-seq."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Assay for Transposase-Accessible Chromatin Using Sequencing (ATAC-seq) Data Analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28723572",
                    "endSection": "abstract",
                    "offsetInBeginSection": 266,
                    "offsetInEndSection": 504,
                    "text": "Here, we apply fluorescent-activated nuclei sorting (FANS) followed by Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) to identify developmentally active endothelial enhancers in the zebrafish genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27146274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 368,
                    "offsetInEndSection": 638,
                    "text": "Our aim was to develop a protocol for freezing neuronal cells that is compatible with ATAC-Seq; we focused on a disease-relevant cell type, namely motor neurons differentiated from induced pluripotent stem cells (iMNs) from a patient affected by spinal muscular atrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24097267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 241,
                    "offsetInEndSection": 501,
                    "text": "ATAC-seq captures open chromatin sites using a simple two-step protocol with 500-50,000 cells and reveals the interplay between genomic locations of open chromatin, DNA-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28723572",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Robust Identification of Developmentally Active Endothelial Enhancers in Zebrafish Using FANS-Assisted ATAC-Seq."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "This unit describes Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq), a method for mapping chromatin accessibility genome-wide."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                "http://www.ncbi.nlm.nih.gov/pubmed/26876161",
                "http://www.ncbi.nlm.nih.gov/pubmed/23840477",
                "http://www.ncbi.nlm.nih.gov/pubmed/28426748",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821439",
                "http://www.ncbi.nlm.nih.gov/pubmed/23869221",
                "http://www.ncbi.nlm.nih.gov/pubmed/27811079",
                "http://www.ncbi.nlm.nih.gov/pubmed/26854857"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 75,
                    "offsetInEndSection": 125,
                    "text": "Well-folded tags can serve to solubilize proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 262,
                    "text": "Small, unfolded, peptide-like tags have become invaluable tools for protein purification as well as protein-protein interaction studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 406,
                    "offsetInEndSection": 559,
                    "text": "Recently, large ID tags have been developed to solubilize proteins and to engineer the pharmacological properties of protein and peptide pharmaceuticals."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 50,
                    "text": "Designing disorder: Tales of the unexpected tails."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "The treatment of carbuncles is early administration of antibiotics and surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 165,
                    "text": "The commonest surgical approaches are saucerization, and incision and drainage (I&D)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "The surgical treatment of carbuncles: a tale of two techniques."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 405,
                    "text": "Intrinsically Disordered Proteins (IDPs), which lack unique 3D structures, received exponentially increasing attention during the last decade."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 736,
                    "offsetInEndSection": 774,
                    "text": "I&D resulted in earlier wound healing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 775,
                    "offsetInEndSection": 881,
                    "text": "A randomized controlled is needed to determine the best surgical approach for the treatment of carbuncles."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                "http://www.ncbi.nlm.nih.gov/pubmed/18469796",
                "http://www.ncbi.nlm.nih.gov/pubmed/12094382",
                "http://www.ncbi.nlm.nih.gov/pubmed/24160789",
                "http://www.ncbi.nlm.nih.gov/pubmed/17195914",
                "http://www.ncbi.nlm.nih.gov/pubmed/21352264",
                "http://www.ncbi.nlm.nih.gov/pubmed/17447970",
                "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                "http://www.ncbi.nlm.nih.gov/pubmed/2442212",
                "http://www.ncbi.nlm.nih.gov/pubmed/2837369"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 41,
                    "text": "Mammary and extramammary Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 860,
                    "text": "The Paget cells in these two conditions seem to have different origins, i.e., those of mammary Paget's disease ascend to the epidermis from lactiferous ducts, whereas those of extramammary Paget's disease originate in the epidermis itself."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 443,
                    "offsetInEndSection": 620,
                    "text": "The conclusion derived from these observations is that the mucin in Paget cells of extramammary Paget's disease is different from that found in cells of mammary Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 408,
                    "text": "Based on the epidermal changes alone, Paget cells in 90% of specimens from lesions of extramammary Paget's disease had abundant mucin that stained well, whereas Paget cells in only 40% of specimens from mammary Paget's disease stained for mucin and faintly at that."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18469796",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Ten cases of mammary Paget's disease and 10 cases of extramammary Paget's disease were studied for differences of histologic features in them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17447970",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 620,
                    "text": "Indeed, mammary Paget's disease is as a rule associated with an underlying breast carcinoma whereas association of extramammary Paget's disease with underlying (skin or visceral) malignancies occurs much less frequently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17447970",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "Paget's disease is an intra-epidermal adenocarcinoma seen over the nipple/areola (mammary Paget's disease) or in extramammary body zones, such as the anogenital and perineal skin and the axilla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Paget's disease of the nipple is often found in conjunction with underlying ductal carcinoma in situ (DCIS)."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                "http://www.ncbi.nlm.nih.gov/pubmed/3541135",
                "http://www.ncbi.nlm.nih.gov/pubmed/2161820",
                "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                "http://www.ncbi.nlm.nih.gov/pubmed/12841932",
                "http://www.ncbi.nlm.nih.gov/pubmed/11399858",
                "http://www.ncbi.nlm.nih.gov/pubmed/9158769",
                "http://www.ncbi.nlm.nih.gov/pubmed/6269488",
                "http://www.ncbi.nlm.nih.gov/pubmed/810136"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 644,
                    "offsetInEndSection": 751,
                    "text": "The non-fragilis species of Bacteroides produce beta-lactamases that are mainly penicillinase in character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 668,
                    "text": "Recent studies have also shown that B. fragilis can produce a penicillinase which inactivates piperacillin and carbenicillin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 851,
                    "offsetInEndSection": 928,
                    "text": "Recently a penicillinase from Fusobacterium nucleatum has been characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 236,
                    "text": "The known mechanisms of beta-lactam resistance in anaerobic bacteria involve production of beta-lactamases, alteration of penicillin-binding proteins, and blocked penetration of beta-lactam antibiotics through bacterial outer membranes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 542,
                    "text": "beta-Lactam resistance in Bacteroides fragilis is commonly mediated by beta-lactamases that are mainly cephalosporinase in character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 755,
                    "offsetInEndSection": 850,
                    "text": "The Bacteroides non-fragilis species produce beta-lactamases of mainly penicillinase character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135",
                    "endSection": "abstract",
                    "offsetInBeginSection": 567,
                    "offsetInEndSection": 684,
                    "text": "Studies have also shown that B. fragilis can produce a penicillinase that inactivates piperacillin and carbenicillin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 408,
                    "text": "The most important factor in beta-lactam resistance is production of beta-lactamases, which have been found in various Bacteroides, Fusobacterium, and Clostridium species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 403,
                    "offsetInEndSection": 542,
                    "text": "Beta-lactam resistance in Bacteroides fragilis is most commonly mediated by beta-lactamase production mainly of cephalosporinase character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 643,
                    "text": "B. fragilis strains can also produce penicillinases and enzymes inactivating cefoxitin and imipenem."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                "http://www.ncbi.nlm.nih.gov/pubmed/16772461",
                "http://www.ncbi.nlm.nih.gov/pubmed/21846752",
                "http://www.ncbi.nlm.nih.gov/pubmed/15474307",
                "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                "http://www.ncbi.nlm.nih.gov/pubmed/22233209",
                "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                "http://www.ncbi.nlm.nih.gov/pubmed/28341144",
                "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                "http://www.ncbi.nlm.nih.gov/pubmed/10640803"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "The domestic cat (Felis silvestris catus) has shared an intertwined existence with humans for thousands of years, living on our city streets and in our homes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 338,
                    "text": "Yet, little scientific research has focused on the cognition of the domestic cat, especially in comparison with human's other companion, the domestic dog (Canis lupus familiaris)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "title",
                    "offsetInBeginSection": 31,
                    "offsetInEndSection": 116,
                    "text": "A review of cat (Felis silvestris catus) cognition research past, present and future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 646,
                    "text": "This review surveys the current status of several areas of cat cognition research including perception, object permanence, memory, physical causality, quantity and time discrimination, cats' sensitivity to human cues, vocal recognition and communication, attachment bonds, personality, and cognitive health."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 871,
                    "offsetInEndSection": 1106,
                    "text": "In addition to the scientific value of future work in this area, future research on cat cognition could have an important influence on the management and welfare of pet and free-roaming cats, leading to improved human-cat interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 647,
                    "offsetInEndSection": 784,
                    "text": "Although interest in cat cognition is growing, we still have a long way to go until we have an inclusive body of research on the subject."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 30,
                    "text": "What's inside your cat's head?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The present study explored the feasibility of a hair cortisol assay in domestic cats (Felis silvestris catus) and dogs (Canis familiaris) as a valid and reliable alternative to existing non-invasive techniques for monitoring the hypothalamic-pituitary-adrenal (HPA) axis activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "The evolutionary basis for the feeding behavior of domestic dogs (Canis familiaris) and cats (Felis catus)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15474307",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "A new determination of the house cat (Felis catus) prion protein gene sequence (fPrnp), which has so far been subject of controversy, is reported."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                "http://www.ncbi.nlm.nih.gov/pubmed/22724006",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                "http://www.ncbi.nlm.nih.gov/pubmed/14980504",
                "http://www.ncbi.nlm.nih.gov/pubmed/24725430",
                "http://www.ncbi.nlm.nih.gov/pubmed/21870268",
                "http://www.ncbi.nlm.nih.gov/pubmed/15941718",
                "http://www.ncbi.nlm.nih.gov/pubmed/26268681"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 655,
                    "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 354,
                    "text": "The 11-zinc finger protein CCTC-binding factor (CTCF) employs different sets of zinc fingers to form distinct complexes with varying CTCF- target sequences (CTSs) that mediate the repression or activation of gene expression and the creation of hormone-responsive gene silencers and of diverse vertebrate enhancer-blocking elements (chromatin insulators)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1257,
                    "offsetInEndSection": 1463,
                    "text": "CTCF-binding sites (CTCF-BSs) have been propagated throughout the genome by transposons in certain primate lineages, but CTCF binding has not previously been described in present-day exogenous retroviruses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "abstract",
                    "offsetInBeginSection": 898,
                    "offsetInEndSection": 1094,
                    "text": "CTCF is a zinc-finger protein that binds to an insulator region in genomic DNA and plays a fundamental role in controlling higher order chromatin structure and gene expression in vertebrate cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 832,
                    "offsetInEndSection": 929,
                    "text": "Although conditionally induced CTCF caused the S-phase block, CTCF can also arrest cell division."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1095,
                    "offsetInEndSection": 1256,
                    "text": "We show that CTCF bound to HTLV-1 acts as an enhancer blocker, regulates HTLV-1 mRNA splicing, and forms long-distance interactions with flanking host chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1464,
                    "offsetInEndSection": 1675,
                    "text": "The presence of an ectopic CTCF-BS introduced by the retrovirus in tens of thousands of genomic locations has the potential to cause widespread abnormalities in host cell chromatin structure and gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1315,
                    "text": "While MYC is the well-characterized CTCF target, the inhibitory effects of CTCF on cell growth could not be ascribed solely to repression of MYC, suggesting that additional CTS-driven genes involved in growth-regulatory circuits, such as p19ARF, are likely to contribute to CTCF-induced growth arrest."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "abstract",
                    "offsetInBeginSection": 669,
                    "offsetInEndSection": 897,
                    "text": "Here, we show that CTCF, a key regulator of chromatin structure and function, binds to the provirus at a sharp border in epigenetic modifications in the pX region of the HTLV-1 provirus in T cells naturally infected with HTLV-1."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                "http://www.ncbi.nlm.nih.gov/pubmed/17085780",
                "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                "http://www.ncbi.nlm.nih.gov/pubmed/18496192",
                "http://www.ncbi.nlm.nih.gov/pubmed/16991141",
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/20722494",
                "http://www.ncbi.nlm.nih.gov/pubmed/16149095"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 204,
                    "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1000,
                    "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Mutations in the leucine-rich kinase 2 gene (LRRK 2) encoding dardarin, on chromosome 12, are a common cause of familial and sporadic Parkinson's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 763,
                    "offsetInEndSection": 950,
                    "text": "Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 1189,
                    "text": "Last, mutations in 2 of these genes turned out to be frequent enough to have relevance in clinical practice: parkin mutations are common in early-onset familial and sporadic PD; moreover, emerging data delineate mutations in the LRRK2 gene (encoding the dardarin protein) as a frequent cause of the familial late onset PD forms, and even of few late-onset sporadic cases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16149095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17085780",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 351,
                    "text": "Although most patients suffering from PD have a sporadic disease, several genetic causes have been identified in recent years, including alpha-synuclein, parkin, PINK1, dardarin (LRRK2), and DJ-1."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                "http://www.ncbi.nlm.nih.gov/pubmed/21989989",
                "http://www.ncbi.nlm.nih.gov/pubmed/12351378",
                "http://www.ncbi.nlm.nih.gov/pubmed/15075082",
                "http://www.ncbi.nlm.nih.gov/pubmed/9988267",
                "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                "http://www.ncbi.nlm.nih.gov/pubmed/27732904"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 309,
                    "text": "It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1357,
                    "offsetInEndSection": 1422,
                    "text": "Among these patients, RPS19 was the most frequently mutated gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21989989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 227,
                    "text": "Among these genes, ribosomal protein S19 (RPS19) is mutated most frequently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 231,
                    "text": "The ribosomal protein S19 gene (RPS19) is the most frequently mutated gene in DBA (~25%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                    "endSection": "abstract",
                    "offsetInBeginSection": 196,
                    "offsetInEndSection": 243,
                    "text": "RPS19 is the most frequently mutated RP in DBA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12351378",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 310,
                    "text": "Recent reports show that the ribosomal protein S19 (RPS19) gene is mutated in 25% of all patients with DBA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 540,
                    "text": "In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1423,
                    "offsetInEndSection": 1674,
                    "text": "In addition, decreased RPS19 mRNA expression and p53 overexpression were observed in the Korean DBA patients, which supports the hypothesis that haploinsufficiency and p53 hyperactivation represent a central pathway underlying the pathogenesis of DBA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 183,
                    "text": "Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1216,
                    "text": "The relative mRNA expression of RPS19 estimated using real-time quantitative PCR analysis revealed two- to fourfold reductions in RPS19 mRNA expression in three patients with RPS19 mutations, and p53 protein expression analysis by immunohistochemistry showed variable but significant nuclear staining in the DBA patients."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                "http://www.ncbi.nlm.nih.gov/pubmed/6954502",
                "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                "http://www.ncbi.nlm.nih.gov/pubmed/12219078",
                "http://www.ncbi.nlm.nih.gov/pubmed/23902875",
                "http://www.ncbi.nlm.nih.gov/pubmed/26021927",
                "http://www.ncbi.nlm.nih.gov/pubmed/26430052",
                "http://www.ncbi.nlm.nih.gov/pubmed/24218638",
                "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                "http://www.ncbi.nlm.nih.gov/pubmed/23542050"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 782,
                    "text": "Together these tools were used to successfully evolve mutant I-SceI homing endonucleases with altered DNA cleavage specificities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 484,
                    "text": "Below we describe the development and successful application of an efficient in vivo positive and negative selection system that applies evolutionary pressure either to favor the cleavage of a desired target sequence or to disfavor the cleavage of nontarget sequences."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Directed evolution and substrate specificity profile of homing endonuclease I-SceI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 783,
                    "offsetInEndSection": 950,
                    "text": "The most highly evolved enzyme cleaves the target mutant DNA sequence with a selectivity that is comparable to wild-type I-SceI's preference for its cognate substrate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "The laboratory evolution of enzymes with tailor-made DNA cleavage specificities would represent new tools for manipulating genomes and may enhance our understanding of sequence-specific DNA recognition by nucleases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 485,
                    "offsetInEndSection": 652,
                    "text": "We also applied a previously described in vitro selection method to reveal the comprehensive substrate specificity profile of the wild-type I-SceI homing endonuclease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6954502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 654,
                    "offsetInEndSection": 823,
                    "text": "By contrast, in two alternating parts, which encode variable arms flanking the central region, deletions and duplications of tandemly repetitive sequences are prominent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1249,
                    "offsetInEndSection": 1408,
                    "text": "The results show that the repetitive sequences are rapidly evolving in the S. purpuratus genome and may serve as a renewable pool of transcriptional enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6954502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 380,
                    "text": "The Hc protein sequence has evolved from a family of more ordinary chorion genes, in large part through fixation of mutations leading to enhanced cysteine content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6954502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 477,
                    "offsetInEndSection": 653,
                    "text": "In two conservative parts, those encoding the amino-terminal signal peptide and the highly structured central region of the protein, only base substitutions have been accepted."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                "http://www.ncbi.nlm.nih.gov/pubmed/27894853",
                "http://www.ncbi.nlm.nih.gov/pubmed/26589645",
                "http://www.ncbi.nlm.nih.gov/pubmed/27456900",
                "http://www.ncbi.nlm.nih.gov/pubmed/25206437",
                "http://www.ncbi.nlm.nih.gov/pubmed/26014322",
                "http://www.ncbi.nlm.nih.gov/pubmed/26330845",
                "http://www.ncbi.nlm.nih.gov/pubmed/6231697"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Seven patients developed symptoms and signs of carpal tunnel syndrome after vehicles they were driving were involved in collisions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 406,
                    "offsetInEndSection": 610,
                    "text": "The findings suggest that injuries inflicted on nonneural structures of the carpal tunnel when the patient was gripping the steering wheel led to chronic compression of the median nerve within the tunnel."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 252,
                    "offsetInEndSection": 405,
                    "text": "The presence of carpal tunnel syndrome was confirmed in every patient by the relief of symptoms following surgical division of the volar carpal ligament."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 944,
                    "offsetInEndSection": 1169,
                    "text": "Our findings revealed bilateral widespread pressure hypersensitivity in subjects with carpal tunnel syndrome, which suggest that widespread central sensitization is involved in patients with unilateral carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 494,
                    "offsetInEndSection": 822,
                    "text": "The results showed that pressure pain threshold levels were significantly decreased bilaterally over the median, ulnar, and radial nerve trunks, the carpal tunnel, the C5-C6 zygapophyseal joint, and the tibialis anterior muscle in patients with unilateral carpal tunnel syndrome as compared to healthy controls (all, P < 0.001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1367,
                    "offsetInEndSection": 1499,
                    "text": "Nevertheless, both central and peripheral sensitization mechanisms are probably involved at the same time in carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 295,
                    "offsetInEndSection": 493,
                    "text": "Pressure pain thresholds were assessed bilaterally over median, ulnar, and radial nerve trunks, the C5-C6 zygapophyseal joint, the carpal tunnel and the tibialis anterior muscle in a blinded design."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 55,
                    "text": "Carpal tunnel syndrome following automobile collisions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 622,
                    "text": "The present review aimed to provide an overview of the pathophysiology of median nerve neuropathy in the carpal tunnel, and subsequent development of CTS."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                "http://www.ncbi.nlm.nih.gov/pubmed/18803461",
                "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                "http://www.ncbi.nlm.nih.gov/pubmed/19592613",
                "http://www.ncbi.nlm.nih.gov/pubmed/24348049",
                "http://www.ncbi.nlm.nih.gov/pubmed/23267843",
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                "http://www.ncbi.nlm.nih.gov/pubmed/26780438",
                "http://www.ncbi.nlm.nih.gov/pubmed/28428687"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 645,
                    "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 897,
                    "offsetInEndSection": 1268,
                    "text": "Considering the current knowledge on the function of mammalian LOX isoforms in ECM remodeling, we propose that LOXL2/L3/L4 members might have preferentially been involved in making cross-linked collagen IV-based basement membrane, whereas the diversification of LOX/L1/L5 forms contributed to chordate/vertebrate-specific ECM innovations, such as elastin and fibronectin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 311,
                    "text": "The best-studied role of LOX enzymes is the remodeling of the extracellular matrix (ECM) in animals by cross-linking collagens and elastin, although intracellular functions have been reported as well."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 951,
                    "offsetInEndSection": 1190,
                    "text": "Immunohistochemistry detected increased LOX within tumour cells and ECM in grade I-IV astrocytic neoplasm compared with normal brain and coincidence of increased LOX with the loss of glial fibrillary acidic protein in higher-grade tumours."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 244,
                    "offsetInEndSection": 403,
                    "text": "We have recently reported the ECM enzyme, lysyl oxidase (LOX), in the central nervous system and observed up-regulation of LOX in anaplastic astrocytoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24348049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 352,
                    "text": "The family of lysyl oxidase (LOX) enzymes cross-links collagens and elastin and, therefore, is a central player in ECM deposition and maturation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 615,
                    "offsetInEndSection": 792,
                    "text": "We identified LOX proteins not only in animals, but also in many other eukaryotes, as well as in bacteria and archaea - which reveals a pre-metazoan origin for this gene family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Lysyl oxidases (LOX) are copper-dependent enzymes that oxidize primary amine substrates to reactive aldehydes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 513,
                    "text": "Five different LOX enzymes have been identified in mammals, LOX and LOX-like (LOXL) 1 to 4, showing a highly conserved catalytic carboxy terminal domain and more divergence in the rest of the sequence."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16538904",
                "http://www.ncbi.nlm.nih.gov/pubmed/27680865",
                "http://www.ncbi.nlm.nih.gov/pubmed/27684269",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                "http://www.ncbi.nlm.nih.gov/pubmed/22918419",
                "http://www.ncbi.nlm.nih.gov/pubmed/27438649",
                "http://www.ncbi.nlm.nih.gov/pubmed/10124108",
                "http://www.ncbi.nlm.nih.gov/pubmed/27425241"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 32,
                    "text": "[Diagnosis of Hansen's disease]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 191,
                    "text": "It acts as a forum for exchanging information related to Hansen's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "The Leprosy Mailing List (LML) is an e-mailing list open to whoever interested in the field from all over the world."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16538904",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "I hope you can use one or two tools in this list to solve an issue you may be having right now, or one that comes up in the future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Christoph Steininger and colleagues explore how multiple infectious, autoimmune, metabolic, and neoplastic diseases have been associated with changes in the intestinal microbiome, although a cause-effect relationship is often difficult to establish."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 463,
                    "offsetInEndSection": 649,
                    "text": "The atlas is divided into three sections, (1) Introduction, (2) Cardinal signs, and (3) Diagnosis and the clinical spectrum of leprosy, and they are all accompanied with relevant photos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 808,
                    "offsetInEndSection": 1009,
                    "text": "RESULTS\nPatient characteristics, prior diseases, clinical presentation, ejection fraction, procedural success and lost-for-follow-up did not differ between patients treated with the SeQuent Please and."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16538904",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 360,
                    "text": "Please, please, please, do not try the more extensive (and potentially more troublesome) options unless you have a lot of experience working on computers or you are 100% certain you do not need any data that is on that computer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 914,
                    "offsetInEndSection": 1009,
                    "text": "For more information, please refer to the homepage where you will find all photos in the atlas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 462,
                    "text": "He and his colleague have recently introduced an atlas for diagnosing Hansen's disease which they brought together information and photos collected through the LML."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                "http://www.ncbi.nlm.nih.gov/pubmed/23230501",
                "http://www.ncbi.nlm.nih.gov/pubmed/18808328",
                "http://www.ncbi.nlm.nih.gov/pubmed/19005043",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                "http://www.ncbi.nlm.nih.gov/pubmed/20221768",
                "http://www.ncbi.nlm.nih.gov/pubmed/26140380",
                "http://www.ncbi.nlm.nih.gov/pubmed/23721465",
                "http://www.ncbi.nlm.nih.gov/pubmed/24198808",
                "http://www.ncbi.nlm.nih.gov/pubmed/7606529"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 236,
                    "text": "The present study examined differences in olfactory sensitivity between 16 naturally cycling (NC) women and 17 women taking monophasic oral contraceptives (OCs) to six odors: lemon, peppermint, rose, musk, androstenone and androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501",
                    "endSection": "abstract",
                    "offsetInBeginSection": 292,
                    "offsetInEndSection": 424,
                    "text": "The purpose of this study was to evaluate the effect of upper complete denture on gustatory and olfactory senses in denture wearers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501",
                    "endSection": "abstract",
                    "offsetInBeginSection": 70,
                    "offsetInEndSection": 291,
                    "text": "Clinical experience suggests that complete denture wearers have various disorders in their gustatory and olfactory senses due to disturbance of airways between the oral and nasal cavities caused by upper complete denture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 395,
                    "offsetInEndSection": 527,
                    "text": "NC women in the periovulatory phase were significantly more sensitive to androstenone, androsterone, and musk than women taking OCs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Evaluation of the effect of upper complete denture on gustatory and olfactory senses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1620,
                    "offsetInEndSection": 1697,
                    "text": "CONCLUSION\nDenture wearing does not influence gustatory and olfactory senses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "Olfactory sensitivity to two odorants, isoamyl acetate and androsterone, was assessed in 14 obsessive compulsive disorder (OCD) patients, nine major depressive disorder (MDD) patients, and 16 sex- and age-matched healthy controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18808328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "The mammalian olfactory system senses an almost unlimited number of chemical stimuli and initiates a process of neural recognition that influences nearly every aspect of life."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20221768",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 319,
                    "text": "In health and disease, it has been shown that in two of these senses, the trigeminal and olfactory senses, modification of one sense leads to changes in the other sense and vice versa."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The relationship between oral contraceptive use and sensitivity to olfactory stimuli."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                "http://www.ncbi.nlm.nih.gov/pubmed/6667428",
                "http://www.ncbi.nlm.nih.gov/pubmed/8654355",
                "http://www.ncbi.nlm.nih.gov/pubmed/2735530",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                "http://www.ncbi.nlm.nih.gov/pubmed/24705744",
                "http://www.ncbi.nlm.nih.gov/pubmed/23767287",
                "http://www.ncbi.nlm.nih.gov/pubmed/9622323"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 568,
                    "text": "Favorable results are obtained in a vertical two-part fracture, by an open reduction and internal fixation of the tarsal navicular body fracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 356,
                    "text": "Analysis based on these cases and on 36 patients suffering from identical fractures reported in the literature led to a new mechanical assumption: the axial compression on the foot, as a result of falling from height, causes impaction of the talus into the body of the navicular bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Fractures of the body of the tarsal navicular bone: case reports and literature review."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 721,
                    "text": "Both an accessory navicular and the body of the navicular bone may develop osteomyelitis in immunocompromised patients; early diagnosis is important for prescribing effective conservative treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Four patients sustaining tarsal navicular body fractures are presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 569,
                    "offsetInEndSection": 657,
                    "text": "In highly comminuted fractures, talo-navicular-cuneiform arthrodesis can be carried out."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 985,
                    "offsetInEndSection": 1160,
                    "text": "For symptomatic pes planus, significant abduction was measured for the navicular relative to the talus and the talar head was plantar flexed relative to the body (p\u2009<\u20090.0083)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 437,
                    "offsetInEndSection": 584,
                    "text": "We also measured orientation of the navicular, morphological parameters of the talus and navicular, and angular position of the talar head to body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 585,
                    "offsetInEndSection": 883,
                    "text": "Pes cavus showed significantly less talonavicular coverage (58\u2009\u00b1\u20092% talus and 86\u2009\u00b1\u20092% navicular) compared to asymptomatic pes planus (63\u2009\u00b1\u20092% and 95\u2009\u00b1\u20092%) and neutrally aligned feet (98\u2009\u00b1\u20092% navicular), and significantly more navicular dorsiflexion and adduction relative to the talus (p\u2009<\u20090.0083)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Osteomyelitis of the accessory and body of the navicular bone: a case report."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/16009312",
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/23919103",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 258,
                    "text": "Dysregulation of the lncRNA known as myocardial infarction-associated transcript (MIAT) has been associated with myocardial infarction."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Myocardial Infarction-Associated Transcript, a Long Noncoding RNA, Is Overexpressed During Dilated Cardiomyopathy Due to Chronic Chagas Disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 340,
                    "text": "Chagas disease causes a severe inflammatory dilated chronic cardiomyopathy (CCC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 624,
                    "text": "A whole-transcriptome analysis of heart biopsy specimens and formalin-fixed, paraffin-embedded samples revealed that MIAT was overexpressed in patients with CCC, compared with subjects with noninflammatory dilated cardiomyopathy and controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 672,
                    "offsetInEndSection": 729,
                    "text": "Results suggest that MIAT is a specific biomarker of CCC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "Long noncoding RNAs (lncRNAs) modulate gene expression at the epigenetic, transcriptional, and posttranscriptional levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 625,
                    "offsetInEndSection": 671,
                    "text": "These results were confirmed in a mouse model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 341,
                    "offsetInEndSection": 381,
                    "text": "We investigated the role of MIAT in CCC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 580,
                    "offsetInEndSection": 784,
                    "text": "It was found that the mRNAs were predominantly involved in certain cardiovascular disease\u2011associated pathway, for example the dilated cardiomyopathy and mitogen\u2011activated protein kinase signaling pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 302,
                    "text": "In the heart, lncRNAs have been implicated in the regulation of development, ischemic and dilated cardiomyopathy, and myocardial infarction."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/18484624",
                "http://www.ncbi.nlm.nih.gov/pubmed/2363420",
                "http://www.ncbi.nlm.nih.gov/pubmed/11767846",
                "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                "http://www.ncbi.nlm.nih.gov/pubmed/19016241",
                "http://www.ncbi.nlm.nih.gov/pubmed/15958794",
                "http://www.ncbi.nlm.nih.gov/pubmed/23146638",
                "http://www.ncbi.nlm.nih.gov/pubmed/19482440"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 841,
                    "offsetInEndSection": 1114,
                    "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 987,
                    "text": "However, comparison of the MSHR genotypes in dizygotic twin pairs discordant for red hair colour indicates that the MSHR gene cannot be solely responsible for the red hair phenotype, since five of 13 pairs tested had both haplotypes identical by state (with three of the five having both identical by descent)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 775,
                    "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1141,
                    "text": "Rather, it is likely that additional modifier genes exist, making variance in the MSHR gene necessary but not always sufficient, for red hair production."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 588,
                    "text": "The previously reported Val92Met allele shows no association with hair colour, but the three alleles Arg151Cys, Arg160Trp and Asp294His were associated with red hair and one Val60Leu variant was most frequent in fair/blonde and light brown hair colours."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "The association between MSHR coding region variation and hair colour in humans has been examined by genotyping 25 red haired and 62 non-red Caucasians, all of whom were 12 years of age and members of a twin pair study."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 238,
                    "offsetInEndSection": 386,
                    "text": "The majority of affected individuals develop some cutaneous melanin; this is predominantly seen as yellow/blond hair, whereas fewer have brown hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1115,
                    "offsetInEndSection": 1195,
                    "text": "This is the first demonstration of a gene modifying the OCA phenotype in humans."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/6263856",
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                "http://www.ncbi.nlm.nih.gov/pubmed/10573394",
                "http://www.ncbi.nlm.nih.gov/pubmed/347245",
                "http://www.ncbi.nlm.nih.gov/pubmed/2988201",
                "http://www.ncbi.nlm.nih.gov/pubmed/344144",
                "http://www.ncbi.nlm.nih.gov/pubmed/6251158",
                "http://www.ncbi.nlm.nih.gov/pubmed/206654",
                "http://www.ncbi.nlm.nih.gov/pubmed/6319524"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 379,
                    "text": "Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "The restriction endonuclease EcoRI dependent recombination of compatible plasmids has been studied in RecA cells of Escherichia coli."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 734,
                    "text": "The finding of phenotypically cryptic ColE1-dependent EcoRI endonuclease activity and the absence of any detectable EcoRI modification system in ColE1-containing cells suggest a control mechanism that appears to prevent functional expression of the ColE1-determined enzyme in vivo."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "[Characteristics of RecA-independent recombination of plasmids in E. coli cells producing restriction endonuclease EcoRI]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 473,
                    "text": "The isolates were initially classified according to their restriction endonuclease profiles using HindIII and EcoRI restriction endonucleases and further characterised by rRNA gene restriction patterns (ribotypes)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6263856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 645,
                    "text": "The restriction endonuclease cleavage maps of the two plasmids, pTB19 and pTB20, were constructed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6263856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1065,
                    "offsetInEndSection": 1148,
                    "text": "Restriction endonuclease cleavage maps of pTB51, pTB52, and pTB53 were constructed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Phenotypically cryptic EcoRI endonuclease activity specified by the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6263856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "Ten plasmids were isolated as covalently closed circular deoxyribonucleic acid from antibiotic-resistant thermophilic bacteria."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                "http://www.ncbi.nlm.nih.gov/pubmed/19127040",
                "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                "http://www.ncbi.nlm.nih.gov/pubmed/11428412",
                "http://www.ncbi.nlm.nih.gov/pubmed/21905781",
                "http://www.ncbi.nlm.nih.gov/pubmed/17290547",
                "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                "http://www.ncbi.nlm.nih.gov/pubmed/19245939",
                "http://www.ncbi.nlm.nih.gov/pubmed/16011530"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 496,
                    "offsetInEndSection": 633,
                    "text": "AIDS is the main predisposing condition for cryptococcal meningitis, and thus the profile of most patients mirrors that of HIV infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 271,
                    "text": "Six hundred and ninety-six cases of cryptococcal meningitis were reported, with a mean incidence of 0.45 per 100,000 inhabitants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The objective of this article was to evaluate the epidemiology of cryptococcal meningitis in Rio de Janeiro State, Brazil, from 1994 to 2004."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 272,
                    "offsetInEndSection": 433,
                    "text": "Patients were predominantly male; mean age was 35.9 years; AIDS was practically the only underlying disease, reported in 61.2% of cases; case-fatality was 51.8%."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 67,
                    "text": "Cryptococcal meningitis in Rio de Janeiro State, Brazil, 1994-2004."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 641,
                    "offsetInEndSection": 736,
                    "text": "INTERPRETATION\nCryptococcal meningitis is a rare disease, often with uncharacteristic symptoms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 708,
                    "text": "Missing information prevented the evaluation of other underlying diseases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 26,
                    "text": "[Cryptococcal meningitis]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 495,
                    "text": "No decline in incidence was observed during the study period."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19127040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "BACKGROUND\nCryptococcal meningitis is a common opportunistic infection in Human Immunodeficiency Virus (HIV)-infected individuals."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23348729",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                "http://www.ncbi.nlm.nih.gov/pubmed/21030426",
                "http://www.ncbi.nlm.nih.gov/pubmed/20961960",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294746",
                "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                "http://www.ncbi.nlm.nih.gov/pubmed/27501156",
                "http://www.ncbi.nlm.nih.gov/pubmed/24513612"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "EPAS1 involves in the hypoxic response and is suggested to be responsible for the genetic adaptation of high-altitude hypoxia in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1617,
                    "offsetInEndSection": 1857,
                    "text": "Our results indicate that several key HIF-regulatory and targeted genes are responsible for adaptation to high altitude in Andeans and Tibetans, and several different chromosomal regions are implicated in the putative response to selection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1042,
                    "offsetInEndSection": 1384,
                    "text": "The CC genotype at rs56721780:G>C and the insertion genotype at -742 indel were found associated with higher EPAS1 and LOX expression levels in amnion, as well as higher birth weight of Tibetan newborns, suggesting that EPAS1 gene might play important roles in the development of amnion, fetus growth and high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1858,
                    "offsetInEndSection": 2100,
                    "text": "These data suggest a genetic role in high-altitude adaption and provide a basis for future genotype/phenotype association studies necessary to confirm the role of selection-nominated candidate genes and gene regions in adaptation to altitude."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1153,
                    "text": "Applying four population genetic statistics commonly used for detecting signatures of natural selection, we identified selection-nominated candidate genes and gene regions in these two populations (Andeans and Tibetans) separately."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "GCH1 plays a role in the high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 405,
                    "offsetInEndSection": 568,
                    "text": "rs56721780:G>C regulated the transcription of EPAS1 by IKAROS family zinc finger 1 (IKZF1), which was identified as a new transcriptional repressor for EPAS1 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 979,
                    "offsetInEndSection": 1092,
                    "text": "Taken together, we propose that GCH1 plays a role in the genetic adaptation of Tibetans to high altitude hypoxia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20961960",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 267,
                    "text": "Genetic studies of Tibetans, an ethnic group with a long-lasting presence on the Tibetan Plateau which is known as the highest plateau in the world, may offer a unique opportunity to understand the biological adaptations of human beings to high-altitude environments."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                "http://www.ncbi.nlm.nih.gov/pubmed/27498420",
                "http://www.ncbi.nlm.nih.gov/pubmed/23037904",
                "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                "http://www.ncbi.nlm.nih.gov/pubmed/22654862",
                "http://www.ncbi.nlm.nih.gov/pubmed/26379628",
                "http://www.ncbi.nlm.nih.gov/pubmed/22535970",
                "http://www.ncbi.nlm.nih.gov/pubmed/20935660"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Brown adipose tissue (BAT) is specialized for energy expenditure, a process called adaptive thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 191,
                    "offsetInEndSection": 275,
                    "text": "Brown adipose tissue (BAT) is responsible for cold-induced thermogenesis in rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Brown adipose tissue (BAT) is the main effector of nonshivering thermogenesis and diet-induced thermogenesis in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27498420",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Brown adipose tissue (BAT) has been also considered as the main thermogenic organ responsible of maintenance body temperature through heat production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 515,
                    "offsetInEndSection": 627,
                    "text": "Concerning energy expenditure, the main effect of estradiol (E2) is on brown adipose tissue (BAT) thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 368,
                    "offsetInEndSection": 436,
                    "text": "PGC1\u03b1 is the master regulator of UCP1-mediated thermogenesis in BAT."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 190,
                    "text": "Fibroblast growth factor-21 (FGF21) is a pleiotropic protein involved in glucose, lipid metabolism and energy homeostasis, with main tissues of expression being the liver and adipose tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23037904",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "PURPOSE OF REVIEW\nThe recent rediscovery of functional cold activated brown adipose tissue (BAT) in adult humans fuelled an uprise in studies on this tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 239,
                    "text": "PET-CT scans recently demonstrated the existence of metabolically active BAT in adult humans, which revitalized our interest in BAT."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/28694499"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1548,
                    "offsetInEndSection": 1676,
                    "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 292,
                    "text": "This card is not recommended for protein analyses, since surface treatment may denature proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 634,
                    "text": "Levels of 82 proteins were assessed in plasma by a proximity extension assay (Proseek Multiplex CVD, Olink Bioscience, Uppsala, Sweden) and related to carotid measures in a regression framework."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 962,
                    "text": "Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80\u00b0C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 362,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 588,
                    "text": "Samples were analyzed by Mesoscale Discovery, Myriad RBM MAP technology and Olink Proseek."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                "http://www.ncbi.nlm.nih.gov/pubmed/18463263",
                "http://www.ncbi.nlm.nih.gov/pubmed/20810002",
                "http://www.ncbi.nlm.nih.gov/pubmed/25794322",
                "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                "http://www.ncbi.nlm.nih.gov/pubmed/17920180",
                "http://www.ncbi.nlm.nih.gov/pubmed/12554604",
                "http://www.ncbi.nlm.nih.gov/pubmed/19194374"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 274,
                    "text": "We hypothesised that a functional polymorphism in the 5' untranslated region of the MAOA gene is associated with specific personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Monoamine oxidase type A (MAOA) has been implicated to be part of mechanisms underlying human temperament and psychiatric disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "Androgen receptor gene (AR), monoamine oxidase A gene (MAOA) and monoamine oxidase B gene (MAOB) have been found to have associations with behavioral traits, such as aggressiveness, and disorders in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 457,
                    "text": "In the present study, we investigated the relationships between a polymorphism involving a variable number of tandem repeats in the promoter of the monoamine oxidase A (MAOA-VNTR) gene and personality traits, as assessed by the Temperament and Character Inventory (TCI)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17920180",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 373,
                    "text": "In the present study, we investigated the variable number of tandem repeats (VNTR) polymorphism of the norepinephrine transporter (NET) and monoamine oxidase A (MAOA), which are major components of the adrenergic system, to elucidate their relationship with personality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "Genetic variants of the monoamine oxidase A (MAOA) have been associated with aggression-, anxiety-, and addiction-related behavior in several nonclinical and clinical populations."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 78,
                    "text": "A regulatory monoamine oxidase a promoter polymorphism and personality traits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 927,
                    "offsetInEndSection": 1099,
                    "text": "We conclude that the structure of this MAOA promoter region does not have a large impact on the expression of personality characteristics in the present Swedish population."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19194374",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20072728",
                "http://www.ncbi.nlm.nih.gov/pubmed/26645980",
                "http://www.ncbi.nlm.nih.gov/pubmed/25791169",
                "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                "http://www.ncbi.nlm.nih.gov/pubmed/27345839",
                "http://www.ncbi.nlm.nih.gov/pubmed/12681518",
                "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                "http://www.ncbi.nlm.nih.gov/pubmed/17767915",
                "http://www.ncbi.nlm.nih.gov/pubmed/10490602"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 667,
                    "text": "Treatment with HDAC inhibitors results in the hyperacetylation of chaperones including heat shock protein (hsp)90, hsp70, hsp40, and the ER-resident hsp70 homolog, glucose-regulated protein 78 (GRP78), which affects their function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 668,
                    "offsetInEndSection": 823,
                    "text": "HDAC inhibitor-mediated deregulation of chaperone function, in turn, deregulates protein homeostasis and induces protein misfolding and proteotoxic stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 417,
                    "offsetInEndSection": 665,
                    "text": "This probe, designated SAHA-BPyne, contains structural elements of the general HDAC inhibitor suberoylanilide hydroxamic acid (SAHA), as well as benzophenone and alkyne moieties to effect covalent modification and enrichment of HDACs, respectively."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 39,
                    "text": "HDAC inhibitors and chaperone function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 303,
                    "text": "Efforts to understand how associated proteins modulate the function of HDACs would benefit from new technologies that evaluate HDAC activity in native biological systems."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 891,
                    "offsetInEndSection": 1113,
                    "text": "These data indicate that certain HDAC-associated proteins are directly modified by SAHA-BPyne, placing them in close proximity to HDAC active sites where they would be primed to regulate substrate recognition and activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 406,
                    "text": "Although the functions of HDAC proteins are becoming apparent both biochemically and clinically, how this class of proteins is regulated remains poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 663,
                    "offsetInEndSection": 733,
                    "text": "We find that monomeric actin is able to bind the class I HDAC complex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26645980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 704,
                    "offsetInEndSection": 850,
                    "text": "Histone deacetylases (HDACs) have recently been recognized as key modulators which control cardiac proteostasis by deacetylating various proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20072728",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Histone deacetylases (HDACs) are a family of proteins that play an important role in regulating transcription as well as the function of a variety of cellular proteins."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                "http://www.ncbi.nlm.nih.gov/pubmed/26275423",
                "http://www.ncbi.nlm.nih.gov/pubmed/8054978",
                "http://www.ncbi.nlm.nih.gov/pubmed/10079758",
                "http://www.ncbi.nlm.nih.gov/pubmed/7816810",
                "http://www.ncbi.nlm.nih.gov/pubmed/2742127",
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/2987505",
                "http://www.ncbi.nlm.nih.gov/pubmed/24590784"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 759,
                    "text": "Centromere cleavage patterns are compatible with a precisely positioned core structure, one in which each of the 16 yeast centromeres is occupied by oppositely oriented Cse4/H4/H2A/H2B hemisomes in two rotational phases within the population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 349,
                    "text": "To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 516,
                    "text": "We find that cleavage patterns at centromeres are unique within the genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse4/H4)2 tetrasomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 332,
                    "text": "To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 708,
                    "offsetInEndSection": 939,
                    "text": "Chromatin immunoprecipitation mapping of selected nucleosome remodelers indicated that asymmetric nucleosomes are bound by the RSC chromatin remodeling complex, which is required for maintaining nucleosomes at asymmetric positions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "The budding yeast Centromere DNA Element II wraps a stable Cse4 hemisome in either orientation in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "In budding yeast, a single cenH3 (Cse4) nucleosome occupies the \u223c120-bp functional centromere, however conflicting structural models for the particle have been proposed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 439,
                    "offsetInEndSection": 707,
                    "text": "Micrococcal nuclease (MNase) sequence-based profiles of asymmetric nucleosome positions revealed a corresponding asymmetry in MNase protection near the dyad axis, suggesting that the loss of DNA contacts around H4S47 is accompanied by protection of the DNA from MNase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 67,
                    "text": "Asymmetric nucleosomes flank promoters in the budding yeast genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 908,
                    "offsetInEndSection": 1077,
                    "text": "Our results indicate that the orientation and rotational position of the stable hemisome at each yeast centromere is not specified by the functional centromere sequence."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27264557",
                "http://www.ncbi.nlm.nih.gov/pubmed/28570559",
                "http://www.ncbi.nlm.nih.gov/pubmed/21073415",
                "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                "http://www.ncbi.nlm.nih.gov/pubmed/24989122",
                "http://www.ncbi.nlm.nih.gov/pubmed/24375106",
                "http://www.ncbi.nlm.nih.gov/pubmed/26484154",
                "http://www.ncbi.nlm.nih.gov/pubmed/24260050",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 633,
                    "text": "Here we show that DNA polymerase \u03b8, despite its minor role in chromosomal DNA repair, substantially contributes to random integration, and that cells lacking both DNA polymerase \u03b8 and DNA ligase IV, which is essential for non-homologous end joining (NHEJ), exhibit 100% efficiency of spontaneous gene targeting by virtue of undetectable levels of random integration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "DNA polymerase theta (pol \u03b8) is encoded in the genomes of many eukaryotes, though not in fungi."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 1152,
                    "text": "However, challenges for expression and purification are presented by the large size of pol \u03b8 (2590 residues in humans) and unusual juxtaposition of domains (a helicase-like domain and distinct DNA polymerase, separated by a region predicted to be largely disordered)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 96,
                    "offsetInEndSection": 149,
                    "text": "Pol \u03b8 is encoded by the POLQ gene in mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21073415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 869,
                    "text": "Gene mutations are mainly consequences of errors of DNA polymerases, especially of their specialized fraction (inaccurate DNA polymerases \u03b2, \u03b6,\u00a0\u03b7, \u03b8, \u03b9, \u03ba, \u03bb, \u00b5, \u03c3, \u03bd, Rev1, and terminal deoxynucleotidyl transferase, and only polymerases \u03b8 and \u03c3 manifest a slight 3'-exonuclease activity) and also consequences of a decrease in the rate of repair of these errors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24375106",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Evidence for moonlighting functions of the \u03b8 subunit of Escherichia coli DNA polymerase III."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28570559",
                    "endSection": "abstract",
                    "offsetInBeginSection": 831,
                    "offsetInEndSection": 1001,
                    "text": "Pol \u03bd-defective mice had no alteration in DNA end-joining during immunoglobulin class-switching, in contrast to animals defective in the related DNA polymerase \u03b8 (pol \u03b8)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 864,
                    "offsetInEndSection": 1005,
                    "text": "Our findings provide new insights into the mechanics of foreign DNA integration and the role of DNA polymerase \u03b8 in human genome maintenance."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                "http://www.ncbi.nlm.nih.gov/pubmed/19796077",
                "http://www.ncbi.nlm.nih.gov/pubmed/19844193",
                "http://www.ncbi.nlm.nih.gov/pubmed/18806224",
                "http://www.ncbi.nlm.nih.gov/pubmed/20170628",
                "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                "http://www.ncbi.nlm.nih.gov/pubmed/19277018",
                "http://www.ncbi.nlm.nih.gov/pubmed/20924363",
                "http://www.ncbi.nlm.nih.gov/pubmed/18545222"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 907,
                    "text": "Intravenous injections with PPMOs restored dystrophin expression in the myocardium and cardiac Purkinje fibers, as well as skeletal muscles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 395,
                    "text": "Exon skipping via synthetic phosphorodiamidate morpholino oligomers (PMOs) represents one of the most promising therapeutic options, yet PMOs have shown very little efficacy in cardiac muscle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1423,
                    "offsetInEndSection": 1591,
                    "text": "The present study reports the rescue of dystrophin expression and recovery of the conduction system in the heart of dystrophic dogs by PPMO-mediated multiexon skipping."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Duchenne muscular dystrophy (DMD) is a lethal genetic disorder caused by an absence of the dystrophin protein in bodywide muscles, including the heart."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1592,
                    "offsetInEndSection": 1761,
                    "text": "We demonstrate that rescued dystrophin expression in the Purkinje fibers leads to the improvement/prevention of cardiac conduction abnormalities in the dystrophic heart."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 848,
                    "text": "administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 298,
                    "text": "Antisense therapy with both chemistries of phosphorodiamidate morpholino oligomers (PMOs) and 2'-O-methyl phosphorothioate has demonstrated the capability to induce dystrophin expression in Duchenne muscular dystrophy (DMD) patients in phase II-III clinical trials with benefit in muscle functions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 396,
                    "offsetInEndSection": 627,
                    "text": "To increase therapeutic potency in cardiac muscle, we tested a next-generation morpholino: arginine-rich, cell-penetrating peptide-conjugated PMOs (PPMOs) in the canine X-linked muscular dystrophy in Japan (CXMDJ) dog model of DMD."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                "http://www.ncbi.nlm.nih.gov/pubmed/27642589",
                "http://www.ncbi.nlm.nih.gov/pubmed/27542248",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                "http://www.ncbi.nlm.nih.gov/pubmed/28253710",
                "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                "http://www.ncbi.nlm.nih.gov/pubmed/27614453"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 747,
                    "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 394,
                    "text": "Also, ciRS-7 acts as a natural competing endogenous RNA, a.k.a."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer's Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 179,
                    "offsetInEndSection": 357,
                    "text": "Recently, miRNA activity has been shown to be affected by the presence of miRNA sponge transcripts, the so-called competing endogenous RNA in humans and target mimicry in plants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "Circular RNAs (circRNAs) are a novel class of non-coding RNA molecules ubiquitously present in the cytoplasm of eukaryotic cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "The emerging landscape of circular RNA ciRS-7 in cancer (Review)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 200,
                    "offsetInEndSection": 330,
                    "text": "A recently identified circRNA, ciRS-7, can regulate the activities of miRNAs, mRNAs, and RBP to exert specific biological effects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1104,
                    "text": "In the mouse brain, we observe overlapping co-expression of ciRS-7 and miR-7, particularly in neocortical and hippocampal neurons, suggesting a high degree of endogenous interaction."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25601048",
                "http://www.ncbi.nlm.nih.gov/pubmed/19710708",
                "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                "http://www.ncbi.nlm.nih.gov/pubmed/19553672",
                "http://www.ncbi.nlm.nih.gov/pubmed/16269686",
                "http://www.ncbi.nlm.nih.gov/pubmed/23690942",
                "http://www.ncbi.nlm.nih.gov/pubmed/23033984",
                "http://www.ncbi.nlm.nih.gov/pubmed/28678867",
                "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1517,
                    "offsetInEndSection": 1764,
                    "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25601048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 709,
                    "offsetInEndSection": 1009,
                    "text": "The families Enterobacteriaceae, Ricketsiaceae, Spiroplasmataceae and Bacillaceae, were the main groups responsible for the specificity of the bee gut while the main families responsible for the specificity of the beebread were Neisseriaceae, Flavobacteriaceae, Acetobacteraceae and Lactobacillaceae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19710708",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1377,
                    "offsetInEndSection": 1613,
                    "text": "Considering the predictive ability and convergence of our phylum-level model, we now propose that deterministic bacterial-bacterial interactions are more important for shaping the human infant gut microbiota than previously anticipated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 577,
                    "text": "Here we reconstructed GEMs for three key species, (Bacteroides thetaiotamicron, Eubacterium rectale and Methanobrevibacter smithii) as relevant representatives of three main phyla in the human gut (Bacteroidetes, Firmicutes and Euryarchaeota)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 845,
                    "text": "As results, 132 bacterial genera and some unidentified operational taxonomic units within 29 phyla in the gut bacteria were detected, with Spirochaetes (11-55%), Firmicutes (7-18%), Bacteroidetes (7-31%), and Proteobacteria (8-14%) as the main phyla, and Treponema, TG5, Dysgonomonas, Tannerella, za29, Lactococcus, Pseudomonas, and SJA-88 as the common genera in all the four termites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19553672",
                    "endSection": "abstract",
                    "offsetInBeginSection": 290,
                    "offsetInEndSection": 501,
                    "text": "Here, we review how members of the Bacteroidetes, one of two dominant gut-associated bacterial phyla, process complex glycans using a series of similarly patterned, cell envelope-associated multiprotein systems."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23690942",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1034,
                    "offsetInEndSection": 1383,
                    "text": "The HuGChip development and validation showed that it is not only able to assess the known human gut microbiota but could also detect unknown species with the explorative probes to reveal the large number of bacterial sequences not yet described in the human gut microbiota, overcoming the main inconvenience encountered when developing microarrays."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25601048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1010,
                    "offsetInEndSection": 1229,
                    "text": "In terms of microbial community structure, the analysis showed that the communities from the two environments were quite different from each other with only 7\u00a0% of species-level taxa shared between bee gut and beebread."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                "http://www.ncbi.nlm.nih.gov/pubmed/16498293",
                "http://www.ncbi.nlm.nih.gov/pubmed/8599063",
                "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                "http://www.ncbi.nlm.nih.gov/pubmed/9402373",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                "http://www.ncbi.nlm.nih.gov/pubmed/6333295",
                "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/2208973"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 234,
                    "offsetInEndSection": 482,
                    "text": "This dramatic case demonstrates that it is important for persons to be vaccinated against yellow fever before they travel to countries where yellow fever is endemic, even if the country, like The Gambia, does not require travelers to be vaccinated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "A Belgian traveler who acquired yellow fever in the Gambia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A 47-year-old Belgian woman acquired yellow fever during a 1-week vacation in The Gambia; she had never been vaccinated against yellow fever."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 233,
                    "text": "She died of massive gastrointestinal bleeding 7 days after the onset of the first symptoms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 495,
                    "text": "According to operational case definition, suspected yellow fever cases are included in case spread sheet with variables like age, sex, locality, occupation, status of vaccination, onset of symptoms, presenting symptoms, date of blood sampling and confirmation of diagnosis either by laboratory results or epidemiological link."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 645,
                    "offsetInEndSection": 735,
                    "text": "All Darfur states (especially Central Darfur) have been affected by Yellow Fever outbreak."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16498293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 234,
                    "offsetInEndSection": 397,
                    "text": "Liver function tests showed severely disturbed function and the diagnosis of yellow fever infection was made by RT-PCR in this patient who had not been vaccinated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 736,
                    "offsetInEndSection": 901,
                    "text": "There is a need to review the non-specific case definition of Yellow Fever which seems to overwhelm the system during outbreaks with cases of other endemic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063",
                    "endSection": "abstract",
                    "offsetInBeginSection": 258,
                    "offsetInEndSection": 362,
                    "text": "He was unvaccinated and had been working in areas where cases of jungle yellow fever had been confirmed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16498293",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "[Biological and pathological data in a case of yellow fever imported from the Gambia]."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19829027",
                "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                "http://www.ncbi.nlm.nih.gov/pubmed/9468757",
                "http://www.ncbi.nlm.nih.gov/pubmed/7819984",
                "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                "http://www.ncbi.nlm.nih.gov/pubmed/2364935",
                "http://www.ncbi.nlm.nih.gov/pubmed/18942220",
                "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                "http://www.ncbi.nlm.nih.gov/pubmed/11125268"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 965,
                    "offsetInEndSection": 1096,
                    "text": "To test for colour-blindness, we used a cognitive approach involving a harbour seal trained to use a concept of same and different."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 376,
                    "text": "Here, we show that dogs exhibit a behavioural response similar to that of red-green blind human subjects when tested with a modified version of a test commonly used for the diagnosis of human deuteranopia (i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19829027",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "OBJECTIVE\nColour blindness might lead to failure in recognizing frank haematuria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19829027",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 345,
                    "text": "PATIENTS AND METHODS\nTwo hundred male patients with bladder cancer were assessed using Ishihara plate test for colour deficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19829027",
                    "endSection": "abstract",
                    "offsetInBeginSection": 588,
                    "offsetInEndSection": 684,
                    "text": "CONCLUSION\nColour blindness was associated with presentation with more advanced bladder tumours."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19829027",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Impact of colour blindness on recognition of haematuria in bladder cancer patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 32,
                    "text": "Are dogs red-green colour blind?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Neurobiological and molecular studies suggest a dichromatic colour vision in canine species, which appears to be similar to that of human red-green colour blindness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18942220",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "PURPOSE\nX-linked red-green colour blindness is the most common form of colour blindness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1024,
                    "offsetInEndSection": 1179,
                    "text": "With coloured stimuli, the difference between normal and red-green colour-blindness is more clear-cut, and red-blind can be discriminated from green-blind."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                "http://www.ncbi.nlm.nih.gov/pubmed/15183541",
                "http://www.ncbi.nlm.nih.gov/pubmed/16158200",
                "http://www.ncbi.nlm.nih.gov/pubmed/25725141",
                "http://www.ncbi.nlm.nih.gov/pubmed/7604203",
                "http://www.ncbi.nlm.nih.gov/pubmed/25321415",
                "http://www.ncbi.nlm.nih.gov/pubmed/11911835",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942292",
                "http://www.ncbi.nlm.nih.gov/pubmed/15253420"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1277,
                    "offsetInEndSection": 1352,
                    "text": "MCF-7/ADR and the breast cancer cell line MCF-7 are not of the same origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 838,
                    "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 327,
                    "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1189,
                    "offsetInEndSection": 1276,
                    "text": "However, the DNA fingerprints of MCF-7/ADR cells did not relate to MCF-7 or MCF-7/ADR'."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1058,
                    "offsetInEndSection": 1188,
                    "text": "With increasing concentrations of ADR, the DNA fingerprints of MCF-7/ADR' cells were always identical to the parental MCF-7 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "MCF-7/ADR cells have been widely used as a multidrug-resistant breast cancer cell model in cancer research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 221,
                    "text": "The origin of MCF-7/ADR has been a matter of debate since MCF-7/ADR cells were re-designated NCI/ADR-RES in 1998."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 314,
                    "text": "To further characterize the tumor origin of the MCF-7 line, cells were grown on collagen-coated cellulos sponges."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                "http://www.ncbi.nlm.nih.gov/pubmed/26351669",
                "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                "http://www.ncbi.nlm.nih.gov/pubmed/18093185",
                "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                "http://www.ncbi.nlm.nih.gov/pubmed/20138170",
                "http://www.ncbi.nlm.nih.gov/pubmed/22025571",
                "http://www.ncbi.nlm.nih.gov/pubmed/12381269",
                "http://www.ncbi.nlm.nih.gov/pubmed/27126993"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 364,
                    "text": "Lumican-transfected PANC-1 cells secreted a 70-kDa lumican protein and had an active ERK pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 991,
                    "offsetInEndSection": 1246,
                    "text": "HT1080 fibrosarcoma cells stably transfected with the lumican cDNA (HT1080/Lum), which express endogenous MT1-MMP, secreted moderate levels of lumican; however, treatment of HT1080/Lum cells with BB94 resulted in accumulation of lumican in culture medium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 409,
                    "text": "Coexpression of MT1-MMP with lumican in HEK293T cells reduced the concentration of lumican secreted into culture medium, and this reduction was abolished by addition of the MMP inhibitor BB94."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 216,
                    "text": "The small leucine-rich proteoglycan lumican was identified from a human placenta cDNA library by the expression cloning method as a gene product that interacts with membrane-type matrix metalloproteinase-1 (MT1-MMP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 410,
                    "offsetInEndSection": 582,
                    "text": "Lumican protein from bovine cornea and recombinant lumican core protein fused to glutathione S-transferase was shown to be cleaved at multiple sites by recombinant MT1-MMP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 583,
                    "offsetInEndSection": 817,
                    "text": "Transient expression of lumican in HEK293 cells induced expression of tumor suppressor gene product p21/Waf-1, which was abrogated by the coexpression of MT1-MMP concomitant with a reduction in lumican concentration in culture medium."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 449,
                    "text": "Lumican is a secreted proteoglycan that regulates collagen fibril assembly."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                "http://www.ncbi.nlm.nih.gov/pubmed/23974699",
                "http://www.ncbi.nlm.nih.gov/pubmed/21781746",
                "http://www.ncbi.nlm.nih.gov/pubmed/10620362",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                "http://www.ncbi.nlm.nih.gov/pubmed/10887954",
                "http://www.ncbi.nlm.nih.gov/pubmed/8689947",
                "http://www.ncbi.nlm.nih.gov/pubmed/9514072"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Induction of cytochrome P450 3A (CYP3A) has been suggested as a mechanism of action of ursodeoxycholic acid (UDCA) in cholestasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                    "endSection": "abstract",
                    "offsetInBeginSection": 996,
                    "offsetInEndSection": 1232,
                    "text": "Most antihuman immunodeficiency virus protease inhibitors are CYP3A substrates and their interactions with rifamycins are a source of major concern in patients coinfected with human immunodeficiency virus and Mycobacterium tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                    "endSection": "abstract",
                    "offsetInBeginSection": 687,
                    "offsetInEndSection": 857,
                    "text": "In TgCYP3A4/hPXR mice, CYP3A4 was strongly induced by rifampicin, a human-specific PXR ligand, but not by pregnenolone 16alpha-carbonitrile, a rodent-specific PXR ligand."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1355,
                    "offsetInEndSection": 1532,
                    "text": "In contrast, administration of rifampicin markedly induced CYP3A metabolism, resulting in abolished budesonide plasma levels and high urinary excretion of 6beta-hydroxycortisol."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23974699",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Cytochrome P450 (CYP) 1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A are major factors involved in the metabolism of clinically prescribed drugs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 224,
                    "text": "Induction of the cytochrome P450 (CYP) family of enzymes by coadministered compounds can result in drug-drug interactions, as in the case of the coadministration of rifampicin with many CYP3A substrates, including midazolam."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 489,
                    "text": "Therefore, we compared the induction potential of UDCA with that of the prototypical inducer rifampicin in a human model study with the CYP3A substrates budesonide and cortisol."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 158,
                    "text": "The effect of rifampicin on cytochrome P450 isoforms in the CYP1A and CYP3A subfamilies has been studied in 72-h cultured precision-cut human liver slices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23974699",
                    "endSection": "abstract",
                    "offsetInBeginSection": 782,
                    "offsetInEndSection": 956,
                    "text": "The induced CYP2C19 and CYP3A activities remained elevated at 4 days after rifampicin discontinuation and returned to baseline levels 8 days after rifampicin discontinuation."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18648005",
                "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                "http://www.ncbi.nlm.nih.gov/pubmed/7418256",
                "http://www.ncbi.nlm.nih.gov/pubmed/7284984",
                "http://www.ncbi.nlm.nih.gov/pubmed/18772439",
                "http://www.ncbi.nlm.nih.gov/pubmed/12127726",
                "http://www.ncbi.nlm.nih.gov/pubmed/9310467",
                "http://www.ncbi.nlm.nih.gov/pubmed/21478459",
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/3460176"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "We have recently identified a common ALL patient which harboured a chromosomal fusion between the TEL gene on chromosome 12 and the ABL gene on chromosome 9."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7284984",
                    "endSection": "abstract",
                    "offsetInBeginSection": 205,
                    "offsetInEndSection": 372,
                    "text": "We hypothesize that the near tetraploid chromosome number present in the tumor cells in both patients may be the product of fusion of two near diploid malignant cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9310467",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18648005",
                    "endSection": "abstract",
                    "offsetInBeginSection": 956,
                    "offsetInEndSection": 1088,
                    "text": "The leukemia-initiating cells generated by Mll fusions or by Ews-ERG fusion can be committed cells within the hematopoietic pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18648005",
                    "endSection": "abstract",
                    "offsetInBeginSection": 709,
                    "offsetInEndSection": 955,
                    "text": "We show that MLL fusions have the capacity to cause hematopoietic tumors only if expressed in permissive cells and that the Mll-Enl fusion can cause lineage reassignment if the chromosomal translocation occurs in lineage noncommitted progenitors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18772439",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18648005",
                    "endSection": "abstract",
                    "offsetInBeginSection": 484,
                    "offsetInEndSection": 708,
                    "text": "We have used these models to study leukemias caused by fusions of the mixed lineage leukemia (MLL) gene and the Ews-ERG fusion gene to evaluate oncogenicity and elucidate some general principles about translocation products."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9310467",
                    "endSection": "abstract",
                    "offsetInBeginSection": 174,
                    "offsetInEndSection": 423,
                    "text": "Current models expressing the BCR-ABL(p190) chimeric gene fail to consistently reproduce the phenotype with which the fusion gene is associated in human pathology, mainly due to the difficulty of being expressed in the appropriate cell type in vivo."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                "http://www.ncbi.nlm.nih.gov/pubmed/15555457",
                "http://www.ncbi.nlm.nih.gov/pubmed/16054130",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                "http://www.ncbi.nlm.nih.gov/pubmed/20593890",
                "http://www.ncbi.nlm.nih.gov/pubmed/19276185",
                "http://www.ncbi.nlm.nih.gov/pubmed/26268754",
                "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                "http://www.ncbi.nlm.nih.gov/pubmed/27431859"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 399,
                    "text": "Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 585,
                    "text": "Immunohistochemical analysis of MMR protein expression is a hallmark of Lynch syndrome diagnostics, but it cannot distinguish between EPCAM deletion carriers and MSH2 mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "PURPOSE\nLynch syndrome is an inherited tumor predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes, mainly MLH1 and MSH2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1520,
                    "offsetInEndSection": 1671,
                    "text": "EPCAM immunohistochemistry therefore represents a promising novel tool for the identification of Lynch syndrome patients with EPCAM germline deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1381,
                    "offsetInEndSection": 1519,
                    "text": "CONCLUSION\nThese results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 845,
                    "offsetInEndSection": 985,
                    "text": "Multiplex ligation-dependent probe amplification (MLPA) analysis was performed to detect germline deletions of the EPCAM and MSH2 gene loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 704,
                    "text": "We hypothesized that EPCAM protein expression might be altered in tumors from patients with a germline EPCAM deletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1174,
                    "text": "MLPA analysis revealed heterozygous EPCAM deletions in all patients with EPCAM-negative tumors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Analysis of EPCAM protein expression in diagnostics of Lynch syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1303,
                    "offsetInEndSection": 1378,
                    "text": "Two EPCAM deletions were detected in patients with an EPCAM-positive tumor."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29285431",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                "http://www.ncbi.nlm.nih.gov/pubmed/29326482",
                "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                "http://www.ncbi.nlm.nih.gov/pubmed/26417627",
                "http://www.ncbi.nlm.nih.gov/pubmed/24401533",
                "http://www.ncbi.nlm.nih.gov/pubmed/28381919",
                "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                "http://www.ncbi.nlm.nih.gov/pubmed/24672216"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 332,
                    "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 458,
                    "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29285431",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 259,
                    "text": "Herein, we report clinical history and kidney biopsy findings in a patient on apixaban (Eliquis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29326482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 426,
                    "text": "Methods: Apixaban suspensions were prepared from commercially available 5-mg Eliquis tablets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                    "endSection": "abstract",
                    "offsetInBeginSection": 927,
                    "offsetInEndSection": 1099,
                    "text": "The proposed spectrofluorimetric methods were successfully applied for the determination of apixaban in Eliquis tablets and tirofiban HCl in Aggrastat intravenous infusion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26417627",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 66,
                    "text": "Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28381919",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "PURPOSE\nTo increase patient knowledge about apixaban (Eliquis, Bristol-Myers Squibb) using an educational video delivered in an urban inpatient setting."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29285431",
                    "endSection": "abstract",
                    "offsetInBeginSection": 740,
                    "offsetInEndSection": 955,
                    "text": "Considering that the onset of this AKI was associated with apixaban treatment initiation, we propose that this patient had ARN associated with factor Xa inhibitor (apixaban), which has not previously been described."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                "http://www.ncbi.nlm.nih.gov/pubmed/28750496",
                "http://www.ncbi.nlm.nih.gov/pubmed/27856627",
                "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                "http://www.ncbi.nlm.nih.gov/pubmed/28790016",
                "http://www.ncbi.nlm.nih.gov/pubmed/26802556",
                "http://www.ncbi.nlm.nih.gov/pubmed/22683529",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358680",
                "http://www.ncbi.nlm.nih.gov/pubmed/28654263",
                "http://www.ncbi.nlm.nih.gov/pubmed/25239654"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1078,
                    "text": "The variety and complexity of the different types of tau deposits in the different diseases, however, has resulted in quite a challenge for the development of tau PET tracers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1262,
                    "offsetInEndSection": 1492,
                    "text": "In this review, we summarize recent findings on the most promising tau PET tracers to date, discuss what has been learnt from these findings, and offer some suggestions for the next steps that need to be achieved in a near future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1261,
                    "text": "Extensive work remains in order to fully characterize the binding properties of the tau PET tracers, and to assess their usefulness as an early biomarker of the underlying pathology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 526,
                    "offsetInEndSection": 658,
                    "text": "Selective PET radiotracers for amyloid-\u03b2 are already available, and potential tau tracers are emerging as new-generation biomarkers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28750496",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Folded and misfolded tau is common to many neurodegenerative conditions, collectively termed \"tauopathies\"."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 496,
                    "text": "Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 536,
                    "text": "The advances of molecular imaging in the recent years have now led to the recent development of promising tau-specific tracers for positron emission tomography (PET), such as THK5317, THK5351, AV-1451, and PBB3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26802556",
                    "endSection": "abstract",
                    "offsetInBeginSection": 646,
                    "offsetInEndSection": 802,
                    "text": "Recently, several tau PET tracers have been successfully developed and demonstrated as having high binding affinity and selectivity to tau protein deposits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 198,
                    "offsetInEndSection": 324,
                    "text": "Consequently, it is important to be able to accurately and specifically target tau deposits in vivo in the brains of patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 694,
                    "offsetInEndSection": 902,
                    "text": "Exploring the patterns of tau deposition in vivo for different pathologies will allow discrimination between neurodegenerative diseases, including different tauopathies, and monitoring of disease progression."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                "http://www.ncbi.nlm.nih.gov/pubmed/19762763",
                "http://www.ncbi.nlm.nih.gov/pubmed/16492837",
                "http://www.ncbi.nlm.nih.gov/pubmed/11226110",
                "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                "http://www.ncbi.nlm.nih.gov/pubmed/18799335",
                "http://www.ncbi.nlm.nih.gov/pubmed/20832171",
                "http://www.ncbi.nlm.nih.gov/pubmed/8826485",
                "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                "http://www.ncbi.nlm.nih.gov/pubmed/15105218"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 600,
                    "text": "The ability of the test to show the antinociceptive effect of morphine and acetylsalicylic acid was similar for high and low formalin concentrations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1612,
                    "text": "Formalin concentrations of 1% or higher have to be used when studying the nociceptive response in the late phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 758,
                    "text": "For both these analgesics, a lower dose was needed to induce antinociception in the late phase than in the early phase using the same formalin concentration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762763",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 300,
                    "text": "We investigated, in a formalin test, whether pERK of the dorsal horn is affected by licking."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762763",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "Licking decreases phosphorylation of extracellular signal-regulated kinase in the dorsal horn of the spinal cord after a formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 299,
                    "text": "Subcutaneous formalin injection induces 2 distinct periods of high licking activity: an early phase lasting the first 5 min, and a late phase lasting 20-30 min after the injection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1416,
                    "offsetInEndSection": 1498,
                    "text": "Formalin concentrations of 0.05-0.2% are recommended for studying the early phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 450,
                    "text": "Formalin concentrations of 0.02-0.2% induced only the early phase, while concentrations of 1% or more induced both the early phase and the late phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1292,
                    "offsetInEndSection": 1415,
                    "text": "It was concluded that the formalin concentration should be kept as low as possible to minimize the suffering of the animal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 806,
                    "offsetInEndSection": 947,
                    "text": "In the late phase indomethacin induced antinociception when 1% formalin was used, while no significant effect was observed using 5% formalin."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                "http://www.ncbi.nlm.nih.gov/pubmed/19797793",
                "http://www.ncbi.nlm.nih.gov/pubmed/27495842",
                "http://www.ncbi.nlm.nih.gov/pubmed/19333092",
                "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                "http://www.ncbi.nlm.nih.gov/pubmed/19830087",
                "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                "http://www.ncbi.nlm.nih.gov/pubmed/28357164",
                "http://www.ncbi.nlm.nih.gov/pubmed/19683136"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 370,
                    "text": "Spontaneous spinal epidural hematoma is an uncommon phenomenon and may be of uncertain cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 28,
                    "offsetInEndSection": 184,
                    "text": "OBJECTIVE\nTo report two cases of spontaneous spinal epidural hematoma that completely resolved, clinically and radiographically, without surgical treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 276,
                    "text": "SUMMARY OF BACKGROUND DATA\nThe treatment of spinal epidural hematoma is usually surgical."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 373,
                    "offsetInEndSection": 548,
                    "text": "METHODS\nOne patient with acute onset of complete quadriplegia and another with complete paraplegia caused by spontaneous spinal epidural hematoma were treated without surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 883,
                    "text": "CONCLUSIONS\nSpontaneous spinal epidural hematoma should be considered in the differential diagnosis of sudden onset of spinal cord compression in association with back pain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "PURPOSE\nAlthough intracranial hemorrhage remains a leading cause of death in hemophilia, spinal epidural hematoma is seen rarely."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 914,
                    "offsetInEndSection": 1070,
                    "text": "A 22-yr-old man with a spontaneous spinal epidural hematoma who was receiving warfarin treatment for a mechanical aortic valve is presented in this article."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Spontaneous spinal epidural hematoma is an uncommon cause of spinal cord compression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                    "endSection": "abstract",
                    "offsetInBeginSection": 838,
                    "offsetInEndSection": 960,
                    "text": "Although, spinal epidural hematoma is a rare condition, it can lead to serious complications like spinal cord compression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27495842",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "BACKGROUND\nThe incidence of spinal epidural hematoma (SEH) is estimated to be 1 per 1,000,000 patients per year; SEH can be classified as idiopathic, spontaneous, and secondary."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9635424",
                "http://www.ncbi.nlm.nih.gov/pubmed/8980137",
                "http://www.ncbi.nlm.nih.gov/pubmed/18756529",
                "http://www.ncbi.nlm.nih.gov/pubmed/21933837",
                "http://www.ncbi.nlm.nih.gov/pubmed/9536080",
                "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                "http://www.ncbi.nlm.nih.gov/pubmed/10434299",
                "http://www.ncbi.nlm.nih.gov/pubmed/19692580",
                "http://www.ncbi.nlm.nih.gov/pubmed/7581375"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9635424",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8980137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Five neurodegenerative diseases are caused by proteins with expanded polyglutamine domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9635424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Spinocerebellar ataxia type 3 (SCA3/MJD) is one of at least eight human neurodegenerative diseases caused by glutamine-repeat expansion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9635424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 381,
                    "text": "Targeted expression of the protein with an expanded polyglutamine repeat led to nuclear inclusion (NI) formation and late-onset cell degeneration."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Four inherited neurodegenerative diseases are linked to abnormally expanded repeats of glutamine residues in the affected proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9635424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 234,
                    "text": "We have recreated glutamine-repeat disease in Drosophila using a segment of the SCA3/MJD protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9635424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 659,
                    "text": "The viral antiapoptotic gene P35 mitigated polyglutamine-induced degeneration in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18756529",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 210,
                    "text": "Huntington's disease is one of the several neurodegenerative diseases caused by dominant mutations that expand the number of glutamine codons within an existing poly-glutamine (polyQ) repeat sequence of a gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21933837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 285,
                    "text": "The CAG repeat specifies glutamine, and the expanded polyQ domain mutation confers dominant toxicity on the protein."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                "http://www.ncbi.nlm.nih.gov/pubmed/28137286",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559185",
                "http://www.ncbi.nlm.nih.gov/pubmed/25784758",
                "http://www.ncbi.nlm.nih.gov/pubmed/24717229",
                "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                "http://www.ncbi.nlm.nih.gov/pubmed/22726435",
                "http://www.ncbi.nlm.nih.gov/pubmed/26603343",
                "http://www.ncbi.nlm.nih.gov/pubmed/26798136",
                "http://www.ncbi.nlm.nih.gov/pubmed/25995381"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1298,
                    "offsetInEndSection": 1540,
                    "text": "Comparison of published LMNB1 DamID LADs with LMNB1 and LMNA LiDs identified here by ChIP-seq further shows that LMNA can associate with 'open' chromatin domains displaying euchromatin characteristics, and which are not associated with LMNB1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 775,
                    "text": "Using ChIP-seq, we show the existence of lamin A/C (LMNA) LiDs with distinct gene contents, histone composition enrichment and relationships to lamin B1-interacting domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 266,
                    "offsetInEndSection": 370,
                    "text": "LADs form megabase-size domains at the nuclear periphery, they are gene-poor and mostly heterochromatic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "The nuclear lamina has been shown to interact with the genome through lamina-associated domains (LADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 999,
                    "text": "The extent of genome coverage of lamin A/C (LMNA) LiDs in sonicated or MNase-digested chromatin is similar (\u223c730 megabases); however over half of these domains are uniquely detected in sonicated or MNase-digested chromatin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Distinct features of lamin A-interacting chromatin domains mapped by ChIP-sequencing from sonicated or micrococcal nuclease-digested chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 378,
                    "text": "Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1006,
                    "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "In mammals, the nuclear lamina interacts with hundreds of large genomic regions, termed lamina-associated domains (LADs) that are generally in a transcriptionally repressed state."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 265,
                    "text": "LADs have been identified by DamID, a proximity labeling assay, and more recently by chromatin immunoprecipitation-sequencing (ChIP-seq) of A- and B-type lamins."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11943181",
                "http://www.ncbi.nlm.nih.gov/pubmed/23270814",
                "http://www.ncbi.nlm.nih.gov/pubmed/10441141",
                "http://www.ncbi.nlm.nih.gov/pubmed/20545906",
                "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                "http://www.ncbi.nlm.nih.gov/pubmed/8440257",
                "http://www.ncbi.nlm.nih.gov/pubmed/10926122",
                "http://www.ncbi.nlm.nih.gov/pubmed/16669634",
                "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                "http://www.ncbi.nlm.nih.gov/pubmed/22563470"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Atomic force microscopy (AFM) is used to characterize the structure and interactions of clathrin triskelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23270814",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 253,
                    "text": "Atomic force microscopy (AFM), single molecule force spectroscopy (SMFS), and single particle force spectroscopy (SPFS) are used to characterize intermolecular interactions and domain structures of clathrin triskelia and clathrin-coated vesicles (CCVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11943181",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Clathrin light chains (CLCs) are regulatory subunits of clathrin triskelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "AP-2 and AP-3 are cellular proteins that drive the in vitro polymerization of clathrin triskelia into cage structures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 657,
                    "offsetInEndSection": 784,
                    "text": "Clathrin triskelia and cages were characterized by size, structure, protein concentration, and chelate and gadolinium contents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 605,
                    "text": "Increased numbers of triskelion dimers and assembly intermediates, as well as structures having dimensions similar to those of clathrin cages, are observed when the triskelia were immersed in a low salt, low pH buffer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 540,
                    "offsetInEndSection": 656,
                    "text": "The second approach uses clathrin cages self-assembled from triskelia and designed to carry 432 gadolinium chelates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 300,
                    "text": "The interaction of these two types of assembly proteins (APs) with preassembled clathrin cages has been studied in order to identify the sites on the triskelia required for binding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1051,
                    "offsetInEndSection": 1166,
                    "text": "Clathrin nanoparticles can be constituted as triskelia (18.5 nm in size), and as cages assembled from them (55 nm)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10441141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "A number of models have been proposed for the assembly of clathrin triskelia into coats."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                "http://www.ncbi.nlm.nih.gov/pubmed/4141622",
                "http://www.ncbi.nlm.nih.gov/pubmed/6191815",
                "http://www.ncbi.nlm.nih.gov/pubmed/6203931",
                "http://www.ncbi.nlm.nih.gov/pubmed/2478578",
                "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                "http://www.ncbi.nlm.nih.gov/pubmed/7690856",
                "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                "http://www.ncbi.nlm.nih.gov/pubmed/375239",
                "http://www.ncbi.nlm.nih.gov/pubmed/15969132"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Myelin content is an important marker for neuropathology and MRI generated myelin water fraction (MWF) has been shown to correlate well with myelin content."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Validating myelin water imaging with transmission electron microscopy in a rat spinal cord injury model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1228,
                    "offsetInEndSection": 1391,
                    "text": "From the TEM images, it appears that as myelin degenerates, it tends to form large watery spaces within the myelin sheaths that are not classified as myelin water."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6191815",
                    "endSection": "abstract",
                    "offsetInBeginSection": 859,
                    "offsetInEndSection": 1004,
                    "text": "We propose that MBP, which is responsible in the central nervous system for myelin compaction, is responsible for the stability of this membrane."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 157,
                    "offsetInEndSection": 344,
                    "text": "However, because MWF is based on the amount of signal from myelin water, that is, the water trapped between the myelin lipid bilayers, the reading may depend heavily on myelin morphology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 649,
                    "text": "To investigate what MWF measures in the presence of debris, we compared MWF to transmission electron microscopy (TEM) derived myelin fraction that measures the amount of compact appearing myelin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6203931",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Myelin basic protein and myelin-associated glycoprotein in chronic, relapsing experimental allergic encephalomyelitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 345,
                    "offsetInEndSection": 453,
                    "text": "This is of special concern when there is a mix of intact myelin and myelin debris, as in the case of injury."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6191815",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Myelin basic protein and the stability of the multilamellar myelin structure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4141622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 122,
                    "offsetInEndSection": 382,
                    "text": "These are (1) ;myelin-like' and ;purified myelin', by the technique of Davison and co-workers (Agrawal et al., 1970b) and (2) ;membrane fraction,' ;light myelin' and ;heavy myelin' by the discontinuous-sucrose-gradient procedure described in the present paper."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20117540",
                "http://www.ncbi.nlm.nih.gov/pubmed/23942901",
                "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                "http://www.ncbi.nlm.nih.gov/pubmed/18501554",
                "http://www.ncbi.nlm.nih.gov/pubmed/17296251",
                "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                "http://www.ncbi.nlm.nih.gov/pubmed/3929401",
                "http://www.ncbi.nlm.nih.gov/pubmed/16739129"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1590,
                    "offsetInEndSection": 1720,
                    "text": "In conclusion, Brucella abortus cannot cause spontaneous abortion by altering the mouse cytokine profile towards Th1 in pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23942901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Brucella abortus RB51 is the vaccine strain currently licensed for immunizing cattle against brucellosis in the United States."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20117540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Infection of cattle caused by Brucella abortus (ie, bovine brucellosis) has been of political importance in the United States for many decades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 449,
                    "text": "This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 290,
                    "text": "Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 584,
                    "text": "Forty-eight Swiss white mice were used in this murine model and the S19 strain of Brucella abortus was used in as the infective agent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20117540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 492,
                    "offsetInEndSection": 588,
                    "text": "Other reservoir hosts for this organism and other Brucella spp in cattle have also been visited."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Mouse cytokine profile skewed towards Th2 in pregnancy during infection with Brucella abortus S19 strain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "The bacterium that causes canine abortion has polynucleotide sequences similar, in deoxyribonucleic acid (DNA)-DNA homology studies, to those of Brucella suis and, by inference from previous data, those of B. abortus and B. melitensis as well as B. neotomae."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20117540",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 19,
                    "text": "Bovine brucellosis."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                "http://www.ncbi.nlm.nih.gov/pubmed/8855270",
                "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                "http://www.ncbi.nlm.nih.gov/pubmed/14745010",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                "http://www.ncbi.nlm.nih.gov/pubmed/22118969",
                "http://www.ncbi.nlm.nih.gov/pubmed/11484052",
                "http://www.ncbi.nlm.nih.gov/pubmed/25486780",
                "http://www.ncbi.nlm.nih.gov/pubmed/23914934"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 408,
                    "offsetInEndSection": 669,
                    "text": "Using Bayesian inference and the largest dataset to date, we find strong support for a monophyletic Neanderthal clade outside the diversity of contemporary humans, in agreement with the expectations of the Out-of-Africa replacement model of modern human origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1362,
                    "offsetInEndSection": 1559,
                    "text": "This initial analysis of the Neanderthal genome advances our understanding of the evolutionary relationship of Homo sapiens and Homo neanderthalensis and signifies the dawn of Neanderthal genomics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 524,
                    "text": "The availability of edible insects in East Asia aided the spread of the unaggressive, highly cooperative Neanderthals, who interbred with H. sapiens in Asia, resulting in a higher admixture of Neanderthal DNA in East Asian populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1139,
                    "text": "In contrast, we find that recent results implying that the Neanderthal sequences are products of PCR artifacts are not well supported, suffering from inadequate experimental design and a presumably high percentage (>68%) of chimeric sequences due to \"jumping PCR\" events."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 674,
                    "text": "Several lines of evidence indicate that the 65,250 base pairs of hominid sequence so far identified in the library are of Neanderthal origin, the strongest being the ascertainment of sequence identities between Neanderthal and chimpanzee at sites where the human genomic sequence is different."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1139,
                    "text": "In the Sub-Saharan region, unaffected by Denisovan or Neanderthal interbreeding, H. sapiens interbred with H. heidelbergensis, because high humidity militated against fire-making and allowed the survival of these non-fire-making hominins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                    "endSection": "abstract",
                    "offsetInBeginSection": 534,
                    "offsetInEndSection": 672,
                    "text": "Dental development in later Homo species has been intensely debated, most notably the issue of whether Neanderthals and H. sapiens differ."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 247,
                    "offsetInEndSection": 407,
                    "text": "Recently, however, both the authenticity of the Neanderthal sequences and their phylogenetic position outside contemporary human diversity have been questioned."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1361,
                    "text": "Our finding that the Neanderthal and human genomes are at least 99.5% identical led us to develop and successfully implement a targeted method for recovering specific ancient DNA sequences from metagenomic libraries."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                "http://www.ncbi.nlm.nih.gov/pubmed/3305932",
                "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                "http://www.ncbi.nlm.nih.gov/pubmed/1960490",
                "http://www.ncbi.nlm.nih.gov/pubmed/6130030",
                "http://www.ncbi.nlm.nih.gov/pubmed/1769989",
                "http://www.ncbi.nlm.nih.gov/pubmed/734986",
                "http://www.ncbi.nlm.nih.gov/pubmed/10409813",
                "http://www.ncbi.nlm.nih.gov/pubmed/21935843"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "The concentration of substrate expressed as hypoxanthine capable of reacting with xanthine oxidase to release superoxide free radicals (O2-) was measured in control and Dupuytren's contracture palmar fascia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 350,
                    "offsetInEndSection": 435,
                    "text": "Xanthine oxidase activity was also detected in Dupuytren's contracture palmar fascia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 203,
                    "text": "The prevalence of Dupuytren's contracture and its coincidence with degenerative changes in the hands and feet as well as loss of distal pulses, were studied in 574 55-year-old residents of Malm\u00f6, Sweden."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 713,
                    "offsetInEndSection": 917,
                    "text": "The benefit of allopurinol in the management of Dupuytren's contracture and other fibrotic conditions may thus be explained, as allopurinol binds to xanthine oxidase and prevents release of free radicals."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 609,
                    "text": "These results suggest a greater potential for hypoxanthine-xanthine oxidase generated oxygen free radical formation in Dupuytren's contracture than in control palmar fascia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 290,
                    "offsetInEndSection": 448,
                    "text": "Dupuytren's contracture was more common in men with degenerative changes in the feet and in men with signs of impaired arterial blood flow in the lower limbs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 347,
                    "text": "When both diseases coexist, the presence of rheumatoid hand deformities, especially flexion and ulnar deviation of the metacarpophalangeal joints, may mask the flexion deformity caused by Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 449,
                    "offsetInEndSection": 612,
                    "text": "Men with Dupuytren's contracture had significantly less subcutaneous fat tissue, as measured by a triceps skinfold index, than men without Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Rheumatoid arthritis and Dupuytren's contracture."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                "http://www.ncbi.nlm.nih.gov/pubmed/25794181",
                "http://www.ncbi.nlm.nih.gov/pubmed/26103569",
                "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                "http://www.ncbi.nlm.nih.gov/pubmed/16567973",
                "http://www.ncbi.nlm.nih.gov/pubmed/22547573",
                "http://www.ncbi.nlm.nih.gov/pubmed/14612910",
                "http://www.ncbi.nlm.nih.gov/pubmed/12851335"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Simultaneous purifying selection on the ancestral MC1R allele and positive selection on the melanoma-risk allele V60L in south Europeans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 684,
                    "offsetInEndSection": 1010,
                    "text": "Thus, at least in Spain, regions at opposite ends of the incident UV-B radiation distribution show significantly different frequencies for the melanoma-risk allele V60L (a mutation also associated to red hair and fair skin and even blonde hair), with higher frequency of V60L at those regions of lower incident UV-B radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1393,
                    "text": "RESULTS\nCarrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 \u00d7 10(-6) \u2264 P \u2264 .0007)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794181",
                    "endSection": "abstract",
                    "offsetInBeginSection": 732,
                    "offsetInEndSection": 1244,
                    "text": "The R variants D84E, R142H, R151C, I155T, R160W and D294H were classified as damaging by the majority of the tools while the r variants V60L, V92M and R163Q have been predicted as neutral in most of the programs The combination of the prediction tools results in 14 nsSNPs indicated as the most damaging mutations in MC1R (L48P, R67W, H70Y, P72L, S83P, R151H, S172I, L206P, T242I, G255R, P256S, C273Y, C289R and R306H); C273Y showed to be highly damaging in SIFT, Polyphen-2, MutPred, PANTHER and PROVEAN scores."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 1019,
                    "text": "In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, \u22652 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "In humans, the geographical apportionment of the coding diversity of the pigmentary locus melanocortin-1 receptor (MC1R) is, unusually, higher in Eurasians than in Africans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1011,
                    "offsetInEndSection": 1197,
                    "text": "Besides, using the 1000G south European data, we show that the V60L haplogroup is also characterized by an extended haplotype homozygosity (EHH) pattern indicative of positive selection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 596,
                    "text": "By analyzing 3,142 human MC1R alleles from different regions of Spain in the context of additional haplotypic information from the 1000 Genomes (1000G) Project data, we show that purifying selection is also strong in southern Europe, but not so in northern Europe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 174,
                    "offsetInEndSection": 331,
                    "text": "This atypical observation has been interpreted as the result of purifying selection due to functional constraint on MC1R in high UV-B radiation environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26103569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "BACKGROUND\nThe melanocortin-1-receptor (MC1R) gene regulates human pigmentation and is highly polymorphic in populations of European origins."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                "http://www.ncbi.nlm.nih.gov/pubmed/21933837",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                "http://www.ncbi.nlm.nih.gov/pubmed/15099583",
                "http://www.ncbi.nlm.nih.gov/pubmed/23895768",
                "http://www.ncbi.nlm.nih.gov/pubmed/22539214",
                "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                "http://www.ncbi.nlm.nih.gov/pubmed/20060908",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777061"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "ARM and HEAT motifs are tandemly repeated sequences of approximately 50 amino acid residues that occur in a wide variety of eukaryotic proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 462,
                    "text": "In order to investigate the origin of the stability of these proteins, we dissect the subdomain architecture of the giant repeat protein PR65/A, which comprises 15 \u03b1-helical HEAT repeats, using a series of truncations and deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23895768",
                    "endSection": "abstract",
                    "offsetInBeginSection": 514,
                    "offsetInEndSection": 709,
                    "text": "A structure-based sequence alignment of the \u03b1-helical repeats identified a conserved pattern of hydrophobic or aliphatic residues reminiscent of the consensus sequence of eukaryotic HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 976,
                    "text": "Inspection of these profiles indicated that the individual repeat motifs of all four classes share a common set of seven highly conserved hydrophobic residues, which in proteins of known three-dimensional structure are buried within or between repeats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23895768",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 513,
                    "text": "The structure reveals a crescent-shaped molecule composed of a double layer of \u03b1-helices with seven anti-parallel \u03b1-helical repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "BACKGROUND\nHEAT and ARM repeats occur in a large number of eukaryotic proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "HEAT repeats - versatile arrays of amphiphilic helices working in crowded environments?"
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 43,
                    "text": "Comparison of ARM and HEAT protein repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 303,
                    "offsetInEndSection": 421,
                    "text": "It also rendered the similarity between ARM and HEAT repeats, believed to be evolutionarily related, readily apparent."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                "http://www.ncbi.nlm.nih.gov/pubmed/44662",
                "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                "http://www.ncbi.nlm.nih.gov/pubmed/26599052",
                "http://www.ncbi.nlm.nih.gov/pubmed/5543435",
                "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                "http://www.ncbi.nlm.nih.gov/pubmed/730770",
                "http://www.ncbi.nlm.nih.gov/pubmed/6643499",
                "http://www.ncbi.nlm.nih.gov/pubmed/6437794"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 452,
                    "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Comparison of protein stability in eukaryotic cells has been achieved by cycloheximide, which is an inhibitor of protein biosynthesis due to its prevention in translational elongation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Analysis of Protein Stability by the Cycloheximide Chase Assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1023,
                    "offsetInEndSection": 1172,
                    "text": "The cycloheximide chase procedure permits visualization of the degradation kinetics of the steady state population of a variety of cellular proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 648,
                    "text": "This article describes the use of cycloheximide chase followed by western blotting to specifically analyze protein degradation in the model unicellular eukaryote, Saccharomyces cerevisiae (budding yeast)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 327,
                    "text": "It is broadly used in cell biology in terms of determining the half-life of a given protein and has gained much popularity in cancer research."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 649,
                    "offsetInEndSection": 755,
                    "text": "In this procedure, yeast cells are incubated in the presence of the translational inhibitor cycloheximide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 181,
                    "text": "Protein abundance reflects the integration of the rates of protein synthesis and protein degradation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Regulation of protein abundance is crucial to virtually every cellular process."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23254476",
                "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                "http://www.ncbi.nlm.nih.gov/pubmed/27714673",
                "http://www.ncbi.nlm.nih.gov/pubmed/23376832",
                "http://www.ncbi.nlm.nih.gov/pubmed/28283433",
                "http://www.ncbi.nlm.nih.gov/pubmed/27348448",
                "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                "http://www.ncbi.nlm.nih.gov/pubmed/28679592",
                "http://www.ncbi.nlm.nih.gov/pubmed/26545617",
                "http://www.ncbi.nlm.nih.gov/pubmed/24462375"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 978,
                    "offsetInEndSection": 1226,
                    "text": "Moreover, TPM enabled heavy cargo loading of melanoma exosomes with 5nm superparamagnetic iron oxide nanoparticles (SPION5) while maintaining original exosome size and minimizing exosome aggregation as evidenced by transmission electron microscopy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1304,
                    "offsetInEndSection": 1475,
                    "text": "This provides a simple, label-free means of enriching exogenously modified exosomes and introduces the potential for MRI-driven theranostic exosome investigations in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 218,
                    "text": "Electroporation has previously been used to load exosomes with RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                    "endSection": "abstract",
                    "offsetInBeginSection": 689,
                    "offsetInEndSection": 841,
                    "text": "We selected lactadherin as an exosome tropic protein and developed it as a fusion protein with Gaussia luciferase to label exosomes for in vivo imaging."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Maximizing exosome colloidal stability following electroporation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 219,
                    "offsetInEndSection": 327,
                    "text": "However, investigations into exosome colloidal stability following electroporation have not been considered."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 463,
                    "text": "Herein, we report the development of a unique trehalose pulse media (TPM) that minimizes exosome aggregation following electroporation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 829,
                    "offsetInEndSection": 977,
                    "text": "TPM maximized exosome dispersal post electroporation for both homogenous B16 melanoma and heterogeneous human serum-derived populations of exosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27348448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 487,
                    "offsetInEndSection": 589,
                    "text": "Exosome membranes can be loaded with hydrophobic therapeutics to increase drug stability and efficacy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27348448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 394,
                    "text": "Alternatively, when exosome source cells are unavailable for customized exosome production, exosomes derived from a variety of biological origins can be modified post isolation which is the focus of this article."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                "http://www.ncbi.nlm.nih.gov/pubmed/27300767",
                "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                "http://www.ncbi.nlm.nih.gov/pubmed/24218632",
                "http://www.ncbi.nlm.nih.gov/pubmed/21326370",
                "http://www.ncbi.nlm.nih.gov/pubmed/8508026",
                "http://www.ncbi.nlm.nih.gov/pubmed/27702613",
                "http://www.ncbi.nlm.nih.gov/pubmed/8417365",
                "http://www.ncbi.nlm.nih.gov/pubmed/12610136"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "The human aldolase A gene is transcribed from three alternative promoters, clustered in a small 1.6-kb DNA domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1215,
                    "offsetInEndSection": 1328,
                    "text": "Promoters were primarily evolving under purifying selection but with certain categories of genes evolving faster."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 302,
                    "text": "In transgenic mice, the upstream pN and the downstream pH promoters are ubiquitous, whereas the pM promoter, located between pN and pH, is activated specifically in fast skeletal muscles."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Independence and interdependence of the three human aldolase A promoters in transgenic mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 718,
                    "offsetInEndSection": 947,
                    "text": "We confirm that the pM and pH promoters are activated independently of each other and, in particular, we show that the activation of pM in fast muscle is not responsible for the downregulation of the downstream pH in this tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 371,
                    "offsetInEndSection": 689,
                    "text": "We found that the core promoters have an average rate of nucleotide substitution substantially higher than that at 4-fold degenerate sites and only slightly lower than that for the assumed neutral controls of neighboring noncoding regions, suggesting that core promoters are subject to very weak selective constraints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 948,
                    "offsetInEndSection": 1106,
                    "text": "By contrast, the pN promoter needs the presence of both enhancers to reproduce its correct pattern of activity and is unable to function autonomously in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 370,
                    "text": "Using a new set of high-quality experimentally determined core promoters of the human genome, we conducted a comparative analysis of 2,492 human and rhesus macaque promoters and their neighboring nearly neutral regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24218632",
                    "endSection": "abstract",
                    "offsetInBeginSection": 287,
                    "offsetInEndSection": 521,
                    "text": "Using transgenic mice, we show that the mouse and chimp 2xHAR142 orthologues behave as transcriptional enhancers driving expression of the reporter gene lacZ to a similar NPAS3 expression subdomain in the mouse central nervous system."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27300767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "The glucose-6-phosphatase catalytic 2 (G6PC2) gene is expressed specifically in pancreatic islet beta cells."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23790307",
                "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351313",
                "http://www.ncbi.nlm.nih.gov/pubmed/22385182",
                "http://www.ncbi.nlm.nih.gov/pubmed/25485923",
                "http://www.ncbi.nlm.nih.gov/pubmed/28314985",
                "http://www.ncbi.nlm.nih.gov/pubmed/25523529",
                "http://www.ncbi.nlm.nih.gov/pubmed/16269995",
                "http://www.ncbi.nlm.nih.gov/pubmed/8501344",
                "http://www.ncbi.nlm.nih.gov/pubmed/12516682"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1282,
                    "text": "Unlike warfarin, there are no currently available antidotes for the factor Xa inhibitors although this is an area of interest for current and future studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 623,
                    "text": "Inhibition of clotting factor Xa has been evaluated as a potential target for anticoagulation therapy with the hypothesis that using target-specific therapy will alleviate some of the dosing variability observed with the vitamin K antagonist."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1283,
                    "offsetInEndSection": 1428,
                    "text": "In the event of a life-threatening bleed there are established management strategies to reverse the bleeding effects of the factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23790307",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "New oral anticoagulants which specifically inhibit factor Xa (FXa) or thrombin (FIIa) do not require routine laboratory monitoring."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 719,
                    "offsetInEndSection": 822,
                    "text": "Similar to the vitamin K antagonist, warfarin, all of the factor Xa inhibitors are administered orally."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22385182",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Identification of structural features for 4-methyl-3-(6-[phenyl methylene] amino} pyridine-3-yl)-2H chromen-2-one derivatives as clotting factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22385182",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 504,
                    "text": "Clotting Factor Xa is one such attractive target for the design of new oral anticoagulants because of the unique role factor Xa plays in the coagulation cascade as a connection between the extrinsic and intrinsic pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 624,
                    "offsetInEndSection": 718,
                    "text": "Three factor Xa inhibitors are currently indicated for use in nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23790307",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1018,
                    "offsetInEndSection": 1213,
                    "text": "The fact that there is no specific antidote to reverse the anticoagulant action of the new anticoagulants can impair management of hemorrhagic complications; clinical experience is still limited."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                "http://www.ncbi.nlm.nih.gov/pubmed/14675180",
                "http://www.ncbi.nlm.nih.gov/pubmed/28425111",
                "http://www.ncbi.nlm.nih.gov/pubmed/25454730",
                "http://www.ncbi.nlm.nih.gov/pubmed/19945614",
                "http://www.ncbi.nlm.nih.gov/pubmed/9804357",
                "http://www.ncbi.nlm.nih.gov/pubmed/2420118",
                "http://www.ncbi.nlm.nih.gov/pubmed/26604545",
                "http://www.ncbi.nlm.nih.gov/pubmed/27186702"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 361,
                    "offsetInEndSection": 569,
                    "text": "The keratin 5 and keratin 14 genes encode proteins that form the primary structural components of the basal epidermal keratinocytes, mutations in either of these genes can cause epidermolysis bullosa simplex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 570,
                    "offsetInEndSection": 670,
                    "text": "In this study we sequenced these genes in a family with epidermolysis bullosa simplex Dowling-Meara."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 879,
                    "offsetInEndSection": 1104,
                    "text": "Consistent with the absence of muscular symptoms in these patients, muscle biopsies from several epidermolysis bullosa simplex Ogna members of the Norwegian kindred showed normal staining patterns using antibodies to plectin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 825,
                    "text": "A German family with the phenotypic hallmarks of epidermolysis bullosa simplex Ogna was found to carry an identical de novo mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 138,
                    "offsetInEndSection": 360,
                    "text": "In addition to the palmoplantar distribution seen in other epidermolysis bullosa simplex subtypes, extensive herpetiform blistering spontaneously develops on the trunk and limbs and may lead to scarring or milia formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 427,
                    "offsetInEndSection": 562,
                    "text": "We found that the epidermolysis bullosa simplex Ogna phenotype is due to a site-specific missense mutation within plectin's rod domain."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "A novel mutation in the helix termination peptide of keratin 5 causing epidermolysis bullosa simplex Dowling-Meara."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 426,
                    "text": "We report here a mutation that leads to a dominant form of the disease, epidermolysis bullosa simplex Ogna."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 563,
                    "offsetInEndSection": 691,
                    "text": "Further, we show that epidermolysis bullosa simplex Ogna is not restricted to a single Norwegian kindred as previously believed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14675180",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 438,
                    "text": "Genetic mutations in plectin, a cytoskeleton linker protein expressed in a large variety of tissues including skin, muscle, and nerves, cause epidermolysis bullosa simplex with muscular dystrophy, a recessive inherited disease characterized by blistering of the skin and late onset of muscular dystrophy, and Ogna epidermolysis bullosa simplex, a rare dominant inherited form of epidermolysis bullosa simplex with no muscular involvement."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                "http://www.ncbi.nlm.nih.gov/pubmed/6184614",
                "http://www.ncbi.nlm.nih.gov/pubmed/24903914",
                "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                "http://www.ncbi.nlm.nih.gov/pubmed/22906983",
                "http://www.ncbi.nlm.nih.gov/pubmed/6178551",
                "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                "http://www.ncbi.nlm.nih.gov/pubmed/3493923",
                "http://www.ncbi.nlm.nih.gov/pubmed/24382176"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 512,
                    "text": "Since mast cells clearly play both physiological and pathophysiological functions in the body, it is important to learn about the components of mast cells that drive these responses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24903914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 866,
                    "text": "In many cases, the effects that mast cells have on an immune response are closely associated with the biological actions of the granule compounds that they release, as exemplified by the recent studies showing that mast cell granule proteases account for many of the protective and detrimental effects of mast cells in various inflammatory settings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 342,
                    "text": "This may be associated with mast cells, which are found in all body tissues of an organism, secrete a wide range of biologically active substances and are important in the regulation of repair processes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 11,
                    "text": "Mast cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 888,
                    "offsetInEndSection": 1137,
                    "text": "Recently investigators have demonstrated that mast cell-deficient mice (WBB6F(1)-W/W(v)) can be reconstituted with mast cells derived in vitro from the bone marrow cells of certain gene knock-out mice or genetically-manipulated embryonic stem cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 513,
                    "offsetInEndSection": 887,
                    "text": "The functional roles of mast cell in vivo have been principally characterized by comparing the biological responses in mast cell-deficient mice (WBB6F(1)-W/W(v)), their normal wild-type littermates (WBB6F(1)-+/+) and mast cell deficient mice reconstituted locally or systemically with mast cells cultured from the bone marrow cells of WBB6F(1)-+/+ mice (WBB6F(1)-W/W(v)+MC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24903914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 356,
                    "offsetInEndSection": 516,
                    "text": "When appropriately activated, mast cells undergo degranulation, a process by which these preformed granule compounds are rapidly released into the surroundings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 189,
                    "text": "Mast cells have long been known to play a detrimental role in the pathogenesis of IgE-associated allergic disorders by their ability to release a wide variety of pro-inflammatory mediators."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 190,
                    "offsetInEndSection": 329,
                    "text": "A number of studies, however, have demonstrated that mast cells play a beneficial role in innate host defense against bacterial infections."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1076,
                    "offsetInEndSection": 1299,
                    "text": "Lipid body accumulation in mast cells is mechanistically distinct from the process in adipocytes; for example, it is independent of PPAR\u03b3 up-regulation and does not involve significant accumulation of conjugated glycerides."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20099464",
                "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                "http://www.ncbi.nlm.nih.gov/pubmed/24891049",
                "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                "http://www.ncbi.nlm.nih.gov/pubmed/11470569",
                "http://www.ncbi.nlm.nih.gov/pubmed/10894550",
                "http://www.ncbi.nlm.nih.gov/pubmed/9096671",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                "http://www.ncbi.nlm.nih.gov/pubmed/11540623",
                "http://www.ncbi.nlm.nih.gov/pubmed/25041067"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 777,
                    "offsetInEndSection": 1065,
                    "text": "In addition, mutations induced by solar UV radiation in p53, ras and patched genes of non-melanoma skin cancer cells, and the role of ROS as both a promoter in UV-carcinogenesis and an inducer of UV-apoptosis, are described based primarily on the findings reported during the last decade."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 205,
                    "text": "One large group of phenolics, flavonoids, is considered particularly responsive to ultraviolet (UV) radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 371,
                    "text": "Among types of solar radiation, ultraviolet B (290-320 nm) radiation is highly mutagenic and carcinogenic in animal experiments compared to ultraviolet A (320-400 nm) radiation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Epidermal UV-A absorbance and whole-leaf flavonoid composition in pea respond more to solar blue light than to solar UV radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 372,
                    "offsetInEndSection": 540,
                    "text": "Epidemiological studies suggest that solar UV radiation is responsible for skin tumor development via gene mutations and immunosuppression, and possibly for photoaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                    "endSection": "abstract",
                    "offsetInBeginSection": 949,
                    "offsetInEndSection": 1159,
                    "text": "These results show that pea plants regulate epidermal UV-A absorbance and accumulation of individual flavonoids by perceiving complex radiation signals that extend into the visible region of the solar spectrum."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1160,
                    "offsetInEndSection": 1328,
                    "text": "Furthermore, solar blue light instead of solar UV-B radiation can be the main regulator of phenolic compound accumulation in plants that germinate and develop outdoors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Terrestrial solar ultraviolet (UV) radiation has significant implications for human health and increasing levels are a key concern regarding the impact of climate change."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                    "endSection": "abstract",
                    "offsetInBeginSection": 206,
                    "offsetInEndSection": 333,
                    "text": "However, here we demonstrate that solar blue light stimulates flavonoid biosynthesis in the absence of UV-A and UV-B radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25041067",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 299,
                    "text": "We hypothesized that solar ultraviolet (UV) radiation would protect silver birch seedlings from the detrimental effects of water stress through a coordinated suite of trait responses, including morphological acclimation, improved control of water loss through gas exchange and hydraulic sufficiency."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                "http://www.ncbi.nlm.nih.gov/pubmed/10535368",
                "http://www.ncbi.nlm.nih.gov/pubmed/12781903",
                "http://www.ncbi.nlm.nih.gov/pubmed/24111315",
                "http://www.ncbi.nlm.nih.gov/pubmed/9809896",
                "http://www.ncbi.nlm.nih.gov/pubmed/12744013",
                "http://www.ncbi.nlm.nih.gov/pubmed/23490058"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 453,
                    "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1161,
                    "text": "Apart from atrial fibrillation, there is relatively limited evidence for the role of antithrombotic therapy for other cardiac conditions associated with cardioembolism and how long one should treat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 619,
                    "offsetInEndSection": 801,
                    "text": "Treatment with vitamin K-antagonists substantially reduces the long-term complications associated with cardioembolism in some high-risk patients, for example, in atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 618,
                    "text": "Unsurprisingly, the stroke risk associated with these conditions is highly variable and non-homogenous, with many risk factors additive to the overall risk profile."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 498,
                    "text": "The multiple-causes mortality files from 1980 through 1998 were analyzed for decedents, with atrial fibrillation (International Classification of Diseases, Ninth Revision, code 427.3) listed as one of up to 20 conditions causing death."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "title",
                    "offsetInBeginSection": 74,
                    "offsetInEndSection": 98,
                    "text": "How long is long enough?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 802,
                    "offsetInEndSection": 962,
                    "text": "Careful selection of antithrombotic drug regime needs to be carried out in patients individually to minimise the risk of bleeding encountered with such therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Cardioembolism accounts for approximately 20% of ischaemic strokes, and is associated with high mortality and propensity to recurrences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 287,
                    "text": "Approximately, 30% of ischaemic strokes remain cryptogenic despite improved imaging modalities and technological improvements to identify their cause."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28827596",
                "http://www.ncbi.nlm.nih.gov/pubmed/8557038",
                "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                "http://www.ncbi.nlm.nih.gov/pubmed/21986530",
                "http://www.ncbi.nlm.nih.gov/pubmed/8932384",
                "http://www.ncbi.nlm.nih.gov/pubmed/25081543",
                "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                "http://www.ncbi.nlm.nih.gov/pubmed/27334938",
                "http://www.ncbi.nlm.nih.gov/pubmed/14586398",
                "http://www.ncbi.nlm.nih.gov/pubmed/20679336"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8557038",
                    "endSection": "abstract",
                    "offsetInBeginSection": 446,
                    "offsetInEndSection": 617,
                    "text": "The expression of wild-type p53 can inhibit the transcriptional activity of E2F, and the expression of both E2F1 and DP1 can also downregulate p53-dependent transcription."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Regulation of p53 gene expression by a poxviral transcription factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28827596",
                    "endSection": "abstract",
                    "offsetInBeginSection": 560,
                    "offsetInEndSection": 775,
                    "text": "The modulation of p53 residence times on chromatin requires C-terminal acetylation-a classical mark for transcriptionally active p53-and correlates with the induction of transcription of target genes such as CDKN1a."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8557038",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 445,
                    "text": "We report here that there is a physical and functional interaction between p53 and two of the components of the E2F transcription factors, E2F1 and DP1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28827596",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 321,
                    "text": "Live-cell microscopy has highlighted that transcription factors bind transiently to chromatin but it is not clear if the duration of these binding interactions can be modulated in response to an activation stimulus, and if such modulation can be controlled by post-translational modifications of the transcription factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 272,
                    "offsetInEndSection": 375,
                    "text": "Here, we report that a unique leporipoxviral transcription factor greatly increases levels of p53 mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1299,
                    "text": "These studies document the direct effects of a viral transcription factor on cellular gene expression, specifically that it upregulates p53 transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20679336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 419,
                    "offsetInEndSection": 486,
                    "text": "Indeed p53 is the most well studied mammalian transcription factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8557038",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "One way in which wild-type p53 is able to regulate cell cycle progression is thought to be via the induction of its downstream target gene Waf1/CIP1, thus indirectly regulating the transcriptional activity of E2F."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21986530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1132,
                    "offsetInEndSection": 1208,
                    "text": "Interestingly, P53 element appears to repress the transcription of p35 gene."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                "http://www.ncbi.nlm.nih.gov/pubmed/26005379",
                "http://www.ncbi.nlm.nih.gov/pubmed/23212802",
                "http://www.ncbi.nlm.nih.gov/pubmed/23648635",
                "http://www.ncbi.nlm.nih.gov/pubmed/24713815",
                "http://www.ncbi.nlm.nih.gov/pubmed/29019242",
                "http://www.ncbi.nlm.nih.gov/pubmed/29149174",
                "http://www.ncbi.nlm.nih.gov/pubmed/15907478",
                "http://www.ncbi.nlm.nih.gov/pubmed/26641655"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 437,
                    "text": "Cystatin C, a biomarker of kidney functioning that has been linked to poor health outcomes, was measured in blood."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "OBJECTIVE\nThe study aims to determine whether cystatin C is associated with HIV disease and HIV-associated neurocognitive impairment (NCI)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 997,
                    "text": "A receiver-operator characteristic curve identified that cystatin C levels \u22650.75 mg/L were associated with NCI in the HIV+ group."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 673,
                    "offsetInEndSection": 867,
                    "text": "Among HIV+ participants, those with NCI had higher cystatin C concentrations than those without NCI (d = 0.42, P = 0.055), particularly among participants taking tenofovir (d = 0.78, P = 0.004)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 557,
                    "offsetInEndSection": 672,
                    "text": "RESULTS\nThe HIV+ group had significantly higher cystatin C concentrations than the HIV- group (d = 0.79 P < 0.001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1391,
                    "offsetInEndSection": 1511,
                    "text": "This blood biomarker may be a useful clinical tool to identify older HIV+ persons at greater risk for cognitive decline."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1170,
                    "offsetInEndSection": 1390,
                    "text": "CONCLUSIONS\nOur results confirm that HIV+ older adults have higher cystatin C than HIV- older adults and further identify that cystatin C may be associated with NCI in this population, particularly if they use tenofovir."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1188,
                    "text": "CONCLUSION\nADAMTS13 activity, d-Dimer and cystatin C are associated with retinopathy in type 1 diabetic patients and are promising biomarkers for the diagnosis and monitoring of diabetic retinopathy."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26081889",
                "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                "http://www.ncbi.nlm.nih.gov/pubmed/23286822",
                "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                "http://www.ncbi.nlm.nih.gov/pubmed/20728317",
                "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                "http://www.ncbi.nlm.nih.gov/pubmed/15567136",
                "http://www.ncbi.nlm.nih.gov/pubmed/25116660",
                "http://www.ncbi.nlm.nih.gov/pubmed/15797810"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26081889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 214,
                    "text": "Leishmaniasis is endemic in Turkey and the neighboring countries Iran, Iraq, and Syria."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 26,
                    "text": "[Cutaneous leishmaniasis]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26081889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 312,
                    "text": "causes three main clinical forms: cutaneous, mucocutaneous, and visceral disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 520,
                    "text": "However, in Sri Lanka, L. donovani causes mainly cutaneous leishmaniasis, while visceral leishmaniasis is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26081889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 467,
                    "text": "Two forms are observed in Turkey; visceral leishmaniasis and cutaneous leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20728317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 757,
                    "offsetInEndSection": 853,
                    "text": "Anthroponotic visceral leishmaniasis, caused by L. donovani, occurs mainly in Sudan and Somalia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20728317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 854,
                    "offsetInEndSection": 949,
                    "text": "Zoonotic visceral leishmaniasis, caused by L. infantum, occurs in most countries of the region."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25116660",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 506,
                    "text": "Visceral leishmaniasis causes high morbidity and mortality in the developing world."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                    "endSection": "abstract",
                    "offsetInBeginSection": 303,
                    "offsetInEndSection": 408,
                    "text": "Leishmania donovani is a causative agent of visceral leishmaniasis in South East Asia and Eastern Africa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 233,
                    "text": "Leishmania(Leishmania) infantum, causing cutaneous leishmaniasis, has been described in patients living in areas where visceral leishmaniasis is endemic."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                "http://www.ncbi.nlm.nih.gov/pubmed/23194153",
                "http://www.ncbi.nlm.nih.gov/pubmed/22717419",
                "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                "http://www.ncbi.nlm.nih.gov/pubmed/18315779",
                "http://www.ncbi.nlm.nih.gov/pubmed/16858720",
                "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                "http://www.ncbi.nlm.nih.gov/pubmed/16268469"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 611,
                    "offsetInEndSection": 797,
                    "text": "The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Interactions of warfarin with other drugs or substances can pose a serious problem."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 388,
                    "text": "We assessed three drug information compendia-Clinical Pharmacology, ePocrates, and Micromedex-and the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 521,
                    "text": "The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 911,
                    "offsetInEndSection": 1075,
                    "text": "This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1744,
                    "offsetInEndSection": 2026,
                    "text": "CONCLUSION\nThis assessment of official US product labeling for 50 drugs, biologics, and drug classes known to interact with warfarin, comprising 73 distinct agents, found that 15% failed to mention the interaction, even though the interaction was mentioned in the warfarin labeling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 798,
                    "offsetInEndSection": 910,
                    "text": "These sources were then examined for classification by severity of interaction and the underlying evidence base."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 754,
                    "text": "METHODS\nWe examined the official labeling information approved by the US Food and Drug Administration for the 50 drugs, biologics, and drug classes that were commonly identified by 3 drug information compendia--Clinical Pharmacology, ePocrates(\u00ae), and Micromedex(\u00ae)--and the warfarin US prescribing information (PI) as having an interaction with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 522,
                    "offsetInEndSection": 610,
                    "text": "Of a total of 648 entries from the four sources, only 50 were common to all the sources."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                "http://www.ncbi.nlm.nih.gov/pubmed/25274322",
                "http://www.ncbi.nlm.nih.gov/pubmed/26834368",
                "http://www.ncbi.nlm.nih.gov/pubmed/25879009",
                "http://www.ncbi.nlm.nih.gov/pubmed/24961768",
                "http://www.ncbi.nlm.nih.gov/pubmed/26712259",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973880",
                "http://www.ncbi.nlm.nih.gov/pubmed/25788237",
                "http://www.ncbi.nlm.nih.gov/pubmed/16163658"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 796,
                    "text": "For PTs specialized in acute care, geriatrics and pediatrics, the body part most commonly affected was the low back, while for PTs specialized in orthopedics and neurology, the body part most commonly affected was the neck."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25879009",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 168,
                    "text": "If the tourniquet is not incised, the affected body part becomes ischemic or even necrotic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "In spite of pain in the CRPS limb, clinical observations show patients pay little attention to, and fail to care for, their affected limb as if it were not part of their body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25879009",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 631,
                    "text": "However, if the tourniquet is not cut through, the affected body part may become ischemic and even necrotic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1496,
                    "offsetInEndSection": 1520,
                    "text": "back, wrists and hands)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1015,
                    "offsetInEndSection": 1116,
                    "text": "CONCLUSIONS\nMSDs are common among PTs; the body parts most often affected were the low back and neck."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26834368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 97,
                    "offsetInEndSection": 224,
                    "text": "Because stroke immobilizes the affected body part, balance training uses the healthy body part to complete the target movement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                    "endSection": "abstract",
                    "offsetInBeginSection": 684,
                    "offsetInEndSection": 865,
                    "text": "Participants revealed bizarre perceptions about a part of their body and expressed a desperate desire to amputate this part despite the prospect of further pain and functional loss."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1329,
                    "offsetInEndSection": 1495,
                    "text": "IMPLICATIONS FOR REHABILITATION\nRehabilitation of injured physical therapists needs to address the symptoms of the multiple body parts that are usually affected (e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1501,
                    "offsetInEndSection": 1629,
                    "text": "We propose that body perception disturbance is a more appropriate term than 'neglect-like' symptoms to describe this phenomenon."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21337531",
                "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                "http://www.ncbi.nlm.nih.gov/pubmed/26064878",
                "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                "http://www.ncbi.nlm.nih.gov/pubmed/25352679",
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/18819540",
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 692,
                    "text": "BORSA cannot be classified as either truly methicillin-resistant or truly methicillin-susceptible strains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1003,
                    "offsetInEndSection": 1156,
                    "text": "All MRSA had additional resistance to tetracycline conferred by tet(M), whereas BORSA generally also display resistance to streptomycin conferred by str."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1054,
                    "text": "A Gln(629)-->Pro substitution was common to all ST25 BORSA, but most could be distinguished from one another by additional unique substitutions in the transpeptidase domain."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1), but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 301,
                    "text": "Since it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/L, the in vitro bactericidal activity and pharmacodynamic effect of oxacillin against clinical BORSA isolates was evaluated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18819540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1786,
                    "offsetInEndSection": 1950,
                    "text": "Because one fourth of our staphylococcus strains are mecA negative BORSA and there is no alternative for vancomycin against mecA positive MRSA and Enterococcus spp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1159,
                    "offsetInEndSection": 1301,
                    "text": "Further investigation into \u03b2-lactam dosing strategies against different BORSA strains is warranted in order to avoid possible therapy failure."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                "http://www.ncbi.nlm.nih.gov/pubmed/17574010",
                "http://www.ncbi.nlm.nih.gov/pubmed/15884233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27771768",
                "http://www.ncbi.nlm.nih.gov/pubmed/22644823",
                "http://www.ncbi.nlm.nih.gov/pubmed/12973504",
                "http://www.ncbi.nlm.nih.gov/pubmed/17565757",
                "http://www.ncbi.nlm.nih.gov/pubmed/9514351",
                "http://www.ncbi.nlm.nih.gov/pubmed/26982754"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 734,
                    "offsetInEndSection": 963,
                    "text": "This article offers a theoretical overview and proposes future research to investigate which factors are indeed responsible for the speech problems encountered by patients with the 22q11.2 deletion and identify responsible genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Possible mechanisms and gene involvement in speech problems in the 22q11.2 deletion syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 381,
                    "text": "These findings suggest the possibility that FOXP1 may also contribute to proper speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "The 22q11.2 deletion syndrome represents a contiguous gene syndrome with a highly variable phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 443,
                    "offsetInEndSection": 605,
                    "text": "Recently, a child was reported who presented with a 3p13-14.1 deletion of four genes, including FOXP1, and a constellation of deficits that included speech delay."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Chiari I malformation, delayed gross motor skills, severe speech delay, and epileptiform discharges in a child with FOXP1 haploinsufficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 807,
                    "offsetInEndSection": 936,
                    "text": "The nature of the speech deficit is different from the primary oromotor verbal dyspraxia found in patients with FOXP2 deficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 686,
                    "offsetInEndSection": 806,
                    "text": "This patient presented with speech and motor developmental delays, a Chiari I malformation, and epileptiform discharges."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17574010",
                    "endSection": "abstract",
                    "offsetInBeginSection": 302,
                    "offsetInEndSection": 432,
                    "text": "The gene is located in Xq13 and mutations in MCT8 are responsible for an X-linked condition, Allan-Herndon-Dudley syndrome (AHDS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 448,
                    "text": "One of the prevalent and serious problems encountered by patients with the 22q11.2 deletion is difficulty with speech."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892",
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Clerodendron capitatum (Willd) (family: verbenaceae) is locally named as Gung and used traditionally to treat erectile dysfunction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 439,
                    "offsetInEndSection": 517,
                    "text": "Adjusting for these factors reduced the number of candidate biomarkers by 63%."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Phosphodiesterase activities in transgenic tobacco plants associated with the movement protein of tobacco mosaic virus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 343,
                    "text": "MATERIALS AND METHODS\nProximity extension assays were used to measure 145 proteins in 632 controls and 344 cases with non-communicable diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1827,
                    "offsetInEndSection": 1913,
                    "text": "PdeM, thus, is a novel representative of new subclass of class III phosphodiesterases."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                "http://www.ncbi.nlm.nih.gov/pubmed/28219152",
                "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                "http://www.ncbi.nlm.nih.gov/pubmed/28055004",
                "http://www.ncbi.nlm.nih.gov/pubmed/24681576",
                "http://www.ncbi.nlm.nih.gov/pubmed/23199790",
                "http://www.ncbi.nlm.nih.gov/pubmed/20978399",
                "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                "http://www.ncbi.nlm.nih.gov/pubmed/27486138"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 962,
                    "offsetInEndSection": 1089,
                    "text": "In many applications, path modeling would be the appropriate analysis in addition to a simple Mendelian randomization analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 961,
                    "text": "Path models are suitable for investigating causality, and they should not be mixed up with the term Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1189,
                    "offsetInEndSection": 1323,
                    "text": "Path modeling but not simple Mendelian randomization analysis is well suited to study causality with different levels of 'omics' data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 465,
                    "offsetInEndSection": 592,
                    "text": "We introduce path models as the relevant additional component to the current use of Mendelian randomization studies in 'omics'."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 227,
                    "offsetInEndSection": 352,
                    "text": "The second aim is to contrast Mendelian randomization and path modeling when different 'omics' levels are considered jointly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1188,
                    "text": "CONCLUSIONS\nMendelian randomization and path models use different concepts for causal inference."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "OBJECTIVE\nThe term Mendelian randomization is popular in the current literature."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 770,
                    "offsetInEndSection": 871,
                    "text": "The authors conclude that Mendelian randomization is a powerful addition to etiologic research tools."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 355,
                    "offsetInEndSection": 464,
                    "text": "METHODS\nWe define Mendelian randomization as introduced by Katan in 1986, and review its crucial assumptions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "\"Mendelian randomization\" refers to the random assortment of genes transferred from parent to offspring at the time of gamete formation."
                }
            ]
        }
    ]
}